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Løps- og sykkeløkonomi hos idrettsutøvere; bestemmende faktorer, 
treningsintervensjoner og testing 
Arbeidet som denne doktorgradsavhandlingen er basert på ble utført ved Norges 
teknisk-naturvitenskapelige universitet og Høgskolen i Telemark. Det består av en 
rekke på fem eksperimentelle studier som har undersøkt bestemmende faktorer for 
løps- og sykkeløkonomi, treningsintervensjoner og testmetoder. 
De viktigste målemetodene i dette doktorgradsarbeidet var målinger av 
oksygenopptak under submaksimale og maksimale arbeidsbelastninger, under løp på 
tredemølle og sykling på testergometersykkel. Videre er det blant annet gjennomført 
laktatmålinger, målinger av maksimalstyrke og effekt i strekkapparat i 
underekstremitetene, kraftmålinger under løp og antropometriske målinger av 
idrettsutøverne. 
Det først studiet undersøkte effekten av melkesyre på oksygenkostnaden (CR) ved løp 
på laktatterskel. CR ble signifikant forverret når blodlaktatkonsentrasjonen ble økt fra 
3 til 5 mmL-1.
Studie to undersøkte i hvilken grad en vanlig benyttet inkrementell protokoll for 
måling av oksygenopptak og CR påvirker reliabiliteten på disse målingene. Hastighet 
og relativ intensitet ble funnet å ikke påvirke CR på intensiteter mellom 60 og 90 % av 
maksimalt oksygenopptak. 
I studie tre og fem ble det undersøkt om maksimal styrketrening (knebøy) bedrer løps- 
og sykkeløkonomi og tid til umattelse ved maksimal aerob hastighet. Både løps- og 
sykkeløkonomi ble signifikant forbedret etter 8 ukers maksimal styrketrening som et 
supplement til den vanlige utholdenhetstreningen. Disse forbedringene førte til 
signifikant lenger tid til utmattelse på maksimal aerob hastighet. Verken maksimalt 
oksygenopptak eller kroppsvekt ble forandret. 
Studie fire undersøkte sammenhenger mellom løps-karakteristika, maksimal styrke, 
antropometri og CR. Det ble funnet en signifikant negativ korrelasjon mellom summen 
av peak kraft, eksentrisk og konsentrisk, i hvert løpesteg og CR.
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Abbreviations used in this thesis 
 
APF                       average peak force 
APFtotal                     sum of more than one average peak force 
A-V O2-difference           arteriovenous oxygen difference 
BW                        body weight 
C                          oxygen cost of work (work economy) 
CC                         oxygen cost of cycling  
CE                         cycling economy 
CR                         oxygen cost of running (running economy) 
CT                         contact time 
CV                        coefficient of variance 
DLO2                      pulmonary diffusion capacity 
DLO2                      muscle diffusion capacity 
E                          potentional kinetic and gravitational energy 
equ                        equation 
F                          force 
f                           cyclus frequency in running or cycling 
FEO2                       fraction of expired oxygen 
FIO2                       fraction of inspired oxygen 
h                          hour 
Hb                       hemoglobin concentration 
Hf                         heart frequency 
Hfmax                       maximum heart frequency 
Hfpeak                      peak heart frequency 
kg                         kilogram 
km                         kilometer 
L                          liter 
La-b                      lactate concentration in blood 
LT                         lactate threshold 
m                          meter 
MAP                       maximum aerobic power 
MAS                       maximum aerobic speed 
min                        minute 
 4
mmolL-1                   millimole per liter 
MST                       maximal strength training 
N                          Newton 
Ns-1                       Newton per second  
Nm s-1                     Newton meter per second 
                          muscular efficiency 
O2                         oxygen 
p                          p-value 
PR                         pedaling resistance 
Q                          cardiac output 
r                           correlation coefficient 
R                          respiratory quotient 
RFD                       rate of force development 
RM                        repetition maximum 
RPM                       rounds per minute 
s                          seconds 
SF                         stride frequency 
SL                         stride length 
SD                         standard deviation 
SV                         stroke volume 
TPF                        time to peak force 
VE                        minute ventilation 
VO2                        oxygen uptake (per minute) 
VO2max                     maximum oxygen uptake (per minute) 
VO2peak                     peak oxygen uptake (per minute) 
W                         watt 
WE                        work efficiency 
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Summary
Paper I investigated the effect of lactic acid on oxygen cost of running (CR) in elite athletes. 7 
elite endurance athletes (4 orienteers and 3 cross country skiers) participated in this study. 
The athletes were first tested for CR at 10 kmh-1 and for lactate threshold (LT) on a treadmill 
with 1.5% inclination, and for maximum oxygen uptake (VO2max) at 5.0% inclination. They 
were then tested for CR at their LT velocity with a pre concentration of blood lactate La-b of 
either 3 mmolL-1 or 5 mmolL-1 followed by a crossover. CR deteriorated significantly (5.5 
%) when pre La-b was raised from 3 mmolL-1 to 5 mmolL-1.  
 
Paper II investigated to what extent a commonly used incremental protocol for measuring 
oxygen uptake (VO2) at different velocities affects the reliability of these measurements. 15 
moderately to well trained (9 male and 6 female) endurance athletes participated in this study. 
CR, heart rate (Hf) and La-b during 5 minute runs at velocities ranging from 8.0 to 17 kmh-1, 
representing intensities ranging from 60% to 90% of VO2max was measured on two different 
days in random order. The athletes were also tested for LT, VO2max, maximum aerobic speed 
(MAS) and time to exhaustion at MAS (tMAS). No significant differences in CR between the 
different relative velocities or the different set velocities were found for neither the male or 
for the female athletes, up to 90% of VO2max. The incremental protocol for measuring VO2 at 
different velocities was found not to affect the reliability of these measurements. All athletes 
reached their VO2max while running to exhaustion at MAS. The females showed significantly 
lower VO2max but significantly better CR than the males. At velocities representing intensities 
between 60% and 90% of VO2max, no differences in CR were found. This means that CR 
measured at sub maximal velocities are representative for CR at race velocity for distances 
above 10 000 metres for most runners.  
 
Paper III investigated if maximal strength training (MST) improves CR and tMAS among well 
trained long distance runners on a level treadmill. 17 well trained (9 male and 8 female) 
runners were randomly assigned into either a maximal strength intervention or a control 
group. The intervention group (4 males and 4 females) performed half-squats, 4 sets of 4 
repetitions maximum (RM), three times per week for 8 weeks, as a supplement to their 
normal endurance training. The control group continued their normal endurance training 
during the same period. The intervention manifested significant improvements in 1RM (33.2 
%), rate of force development (RFD) (26.0 %), CR (5.0 %), and tMAS (21.3 %). The control 
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group showed no changes from pre to post values in any of the parameters. Neither the 
intervention group nor the control group changed VO2max or body weight (BW).  
 
The relationship between running characteristics and force measures and CR, as well as the 
relationship between anthropometric factors, maximal strength in lower extremities and CR 
was investigated in paper IV. 11 elite endurance athletes participated in this study. 1RM in 
half-squat leg press, VO2max, CR, vertical and horizontal external forces while running, BW, 
height, leg length, calf circumference, hip width, and body fat, were examined. 3000m best 
performance times obtained during the last season were recorded. The athletes wore contact 
soles, and the treadmill was placed with the front on a force platform while the rear end was 
hanging in a special device constructed for this purpose. Ergospirometric variables were 
measured while the athletes were running at the same treadmill at the same speed as for the 
force measurements. The sum of eccentric and concentric peak forces (APFtotal) revealed a 
significant inverse correlation (p0.05) both with 3000m performance (R=0.71) and CR 
(R=0.66). Moderate inverse correlations were found (p0.05) between CR and body height 
(R=0.61) and between CR and body fat percentage (R=0.62). 
 
Paper V investigated if MST improves cost of cycling (CC), work efficiency (WE) and time to 
exhaustion at maximal aerobic power (tMAP) among competitive road cyclist in line with the 
running improvements in paper III. 16 competitive road cyclists (12 male and 4 female) were 
randomly assigned into either an intervention or a control group. The intervention group (7 
males and 1 female) performed half-squats, 4 sets of 4 RM, three times per week for 8 weeks, 
as a supplement to their regular endurance training. The control group continued their normal 
endurance training during the same period. The intervention resulted in significant 
improvements in 1RM (14.2%), RFD (16.7%), CC (4.8%), WE (4.7%) and tMAP (16.1%). No 
changes were observed in VO2max, BW or cadence. The control group improved WE by 1.4%, 
but this improvement was significantly lower than in the intervention group.  
 
Running performance times were recorded from the subjects in two of the studies (study III, 
and study IV). In study III, seasonal best times in 5 km running were collected from each 
athlete.  CR accounted for 5% of the difference in 5 km performance between these subjects. 
In study IV, seasonal best times in 3 km running were collected from each athlete. CR 
accounted for 13% of the difference in 3 km performance between these subjects. The athletes 
in study IV were more homogenous regarding VO2max than the athletes in study III. 
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 Since some of the variables measured in two or more of the studies on CR were tested in 
identical protocols, results from different studies could be combined in this thesis to gain a 
stronger statistical power. Such a combination was used to further investigate possible gender 
differences in CR as observed in study II. When combining CR results from study II and study 
III, and dividing into gender, there is a significantly (p0.01) better CR for the female subjects 
(0.663  0.039 mlkg-0.75m-1) compared to the male subjects (0.724  0.057 mlkg-0.75m-1). 
When CR results from all the four studies on running are combined independent of gender, 
mean CR was 0.701  0.051 mlkg-0.75m-1, showing an inter-individual variation of 7.3%.  
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Introduction
The energetics of long distance running and cycling 
Endurance Performance  
Endurance performance, as in long distance running and cycling imposes great demands on 
both the cardiovascular system and the muscle system. Although Coyle (1999) defines 
performance in endurance events as: The power or velocity that can be maintained for 
durations of 30 minutes to four hours, long distance running races are commonly regarded as 
races over distances from 3000 m to 42.2 km, while road cycling distances typically range 
from approximately 5 km (short prologues) to approximately 250 km (long road races). This 
gives racing times ranging from approximately 7.30 minutes to approximately 2.30 hours at 
high performance running, and racing times ranging from approximately 10 minutes to 
approximately 6 hours in high performance cycling. Medbø and Tabata (1989) have 
demonstrated a 50 – 50% aerobic / anaerobic energy release already after one minute of 
maximal bicycle ergometer work. As the duration of a work increases, the higher the energy 
release from aerobic processes, reaching approximately 99% for a marathon race (42.2 km) 
(Åstrand and Rodahl 1986). In short time trials, professional road cyclists work at mean heart 
rates between 80% and 90% of maximum heart rate (Hfmax)(Padilla et al 2000), which is 
slightly above the cyclists lactate thresholds (LT).  In longer road races, the mean intensity 
seems to be slightly below LT (Vogt et al 2006).  
In distance running and cycling, anaerobic capacity is thus of minor importance compared to 
the aerobic energy production. An efficient oxygen transport system is thus vital. Endurance 
sports are apparently demanding in terms of aerobic capacity, but performance over more than 
a few minutes is also influenced by somatic factors (e.g. gender, age and body dimensions), 
psychological factors (e.g. attitude, motivation), environment (altitude, heat) and probably 
most of all training adaptations (Maughan et al. 1969, Åstrand and Rodahl 1986).  
 
Physiological determinants of cardio vascular endurance 
Pate and Kriska (1984) have described a model that incorporates the three major factors 
accounting for inter-individual variance in aerobic endurance performance, namely VO2max, 
LT and work economy (C). Numerous published studies support this model (Pollock 1977, 
Farrell et al. 1979, Conley and Krahenbuhl 1980, Di Prampero et al. 1986, Bunc and Heller 
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1989, Hoff et al 2002). Thus, the model should serve as a useful framework for 
comprehensive examination of C and the relevance on endurance performance.  
Maximal oxygen uptake  
VO2max is probably the single most important factor determining success in an aerobic 
endurance sport (Åstrand and Rodal 1986, Saltin 1990). However, within the same person 
VO2max is specific to a given type of activity. Therefore, in order to obtain relevant values, 
emphasis is placed on testing in sport-specific or working specific activities (Strømme et al. 
1977). Wagner (1993, 1996) has devised a numerical analysis interactively linking the lungs, 
circulation and muscles designed to compare the influences of each conductance component 
on VO2max. The four conductances in question are alveolar ventilation (VE), cardiac output 
(Q), pulmonary diffusion capacity (DLO2) and muscle diffusing capacity (DMO2). Two other 
independent transport variables considered are haemoglobin concentration ([Hb]) and the 
fraction of inspired O2 (FIO2). At maximal exercise, the majority of evidence points to a 
VO2max that is limited by O2 supply, and Q is just as influential as [Hb], DLO2 and DMO2 
together (Powers et al. 1989, Wagner 1991, Roca et al. 1992, Knight et al. 1993, Wagner 
1996, Richardson et al. 1999). Andersen and Saltin (1985) have shown that skeletal muscle 
has an ability to consume O2 that vastly exceeds the circulatory systems ability to supply O2. 
This is supported by training interventions aiming to increase Q. Helgerud et al. (2007) have 
shown that aerobic high-intensity intervals improve VO2max and Q more than moderate 
training.  For several groups of patients however, mainly where the disease affects work 
capacity, a demand limitation is proposed (Wang et al 2008).  
Lactate threshold 
The LT was defined by Davis (1985) as the intensity of work or VO2 where the blood lactate 
concentration gradually starts to increase during continuous exercise. The [la-]b represents a 
balance between lactate production and removal, and there are individual patterns in this 
kinetics (Brooks 1986). Lactate is not wasted. Without any loss of energy, the process of 
pyruvate transformation to lactate can be reversed. Pyruvate can thus be oxidized or to a 
lesser extent be a substrate for synthesis of glucose and glycogen. Both the resting and sub 
maximally working skeletal muscle, as well as heart muscle and kidney cortex can use lactate 
as a substrate (Åstrand and Rodal 1986). The relationship between LT expressed as 
percentage of VO2max and aerobic performance capacity is, however debated. It is argued that 
for durations of work up to approximately 30 minutes a person’s ability to utilize a high 
percentage of VO2max over an extended period of time is first and foremost a function of time 
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(Leger 1986, Coetzer et al. 1993). If one person shows better fractional utilization than 
another person, it is because he covers a given distance in a shorter time, and can therefore 
work at a higher relative intensity. When some authors try to express LT as work load 
(Yoshida et al. 1987, Nicholson and Sleivert 2001), it correlates well with performance. 
Performance at LT depends on both  VO2max and C. A correct expression of LT is a % of 
VO2max, and then the adaptability seems to be minor (Bangsbo 1994, Helgerud et al 2001, 
Helgerud et al 2007).  
 
Work economy and work efficiency 
C is referred to as the oxygen cost of a standardised aerobic workload. CR or CC is commonly 
defined as the steady state VO2 in mlkg-1min-1 at a standard velocity or brake power (Conley 
and Krahenbuhl 1980, Costill et al. 1973, Foss and Hallen 2004). CR is also commonly 
defined as energy cost of running per metre (mlkg-1m-1), (Di Prampero et al. 1986, Helgerud 
1994, Helgerud et al. 2001). Conley and Krahenbuhl (1980) and Helgerud (1994) have shown 
inter-individual variations in CR at a standard running velocity.  
 
WE is typically defined as the relationship between mechanical work performed and the 
chemical energy spent in performing it (McMahon 1984, Pate and Kriska 1984, Kent 1994), 
which is the ratio between work output and C (Åstrand and Rodahl 1986, Hoff et al 2005). 
According to Margaria (1976), the maximum efficiency with which a muscle may transfer 
chemical energy into mechanical work during walking or running, is about 25%. To 
accurately measure the total work output during walking or running is, however a difficult 
task (Pate and Kriska 1984), at least on level ground. If mechanical work in walking or 
running is calculated from the product of BW and the net change of the centre of mass per 
step cycle divided by the time spent in completing this cycle, on level ground the mechanical 
work should be zero (McMahon 1984) and thus not useful to measure. When mechanical 
work in walking or running is calculated by use of the equation for kinetic energy 
Work= 2
2
1 mv (equ. 1), where m is the body mass, and v is the velocity at which the runner or 
walker moves, and corrected for the gyration of the limbs around its centre of mass, Cavagna 
and Kaneko (1977) have found WE to increase steadily with increased running speed. 
Maximal muscular efficiency values well above the 25% described by Margaria (1976) are 
shown by Cavagna and Kaneko (1977). They suggest that this is due to passive recoil of 
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muscle elastic elements. Because of the complexity of calculating mechanical work in 
walking and running (Pate and Kriska 1984), it is thus more common to measure C in these 
activities. In cycling, however the force applied in the braking of the flywheel, the 
circumference of the wheel, and the velocity with which the wheel is turning, makes it easy to 
compute the external power output.  
WE is thus easily calculated on cycle ergometer (Mogensen et al 2006): 
myMetabolisBasalEnergnditureEnergyExpe
WorkRateWE
	

  (equ. 2).  
Factors influencing running and cycling economy 
Walking or running mammals, such as humans are very inefficient with regards to the 
energetic cost of moving (Tucker 1975, Margaria 1976). During walking and running, a 
recruited muscle both shortens and lengthens in cycles. As it shortens, it does mechanical 
work, but as it lengthens, mechanical work is done on it (Tucker 1975). According to Tucker 
(1975) there are two main reasons why human locomotion is inefficient. First, as a muscle is 
stretched, it consumes extra metabolic energy at the same time as it is absorbing work. 
Second, as pointed out in Cavanagh et al (1964) about half of the work done by stretching a 
muscle is converted into heat, while the rest is stored in elastic elements. 
CR could thus be represented by the equation presented in Alexander (1984): 
 CR=

fE5.0  (equ. 3) where 0.5 is the approximate amount of energy from braking forces that 
is not stored in elastic elements, f is the step frequency, E is the potential kinetic and 
gravitational energy at each step, and  is the efficiency of muscle action, approximately 0.2, 
as suggested by Alexander (1980). There will be three major ways to improve CR. One is by 
decreasing the braking forces that causes stretching of muscle-tendon units i.e. by decreasing 
vertical movement of the center of mass. All braking forces can, however, not be prevented in 
running. Because of gravity, the center of mass must to some extent be sent upwards (as a 
result of a stem) as it will gradually fall down when it is not supported by the legs. To 
minimize vertical movement of the center of mass will therefore lead to an increase in step 
frequency (f). A second way to improve CR is to increase the amount of energy from the 
braking forces that can be stored in elastic elements in muscle-tendon units i.e. elastic recoil. 
A third way in which CR may be improved is by increasing muscular efficiency. 
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In cycling, vertical movement of the center of mass is minimal, unless riding uphill. The 
braking forces are first and foremost represented by the resistance to the cyclist and bicycle 
moving forward, and transferred to the pedals. The resistance to the cyclist moving forward is 
represented by the resistance to the rolling tyres, air resistance and gravitational energy if 
riding up hill. On an ergometer, the resistance is represented by the artificial braking of the 
flywheel and transferred to the pedals. A modified version of the equation for CR presented in 
Alexander (1984), and applied to CC can thus be CC=

RfP ( equ.4) where f is the pedaling 
frequency (cadence), PR is pedaling resistance at each round, and  is the efficiency of muscle 
action, still approximately 0.2, as suggested by Alexander (1980). According to Faria (1992), 
air resistance is by far the greatest retarding force affecting cycling. Consequently, the 
aerodynamics should be a major factor influencing CC. At speeds above 30 kmh-1, air 
resistance account for more than 90% of the total resistance the cyclist encounter. However, 
air resistance will not contribute to pedaling resistance on an ergometer cycle in a laboratory. 
At a given power, pedaling resistance will then be directly influenced by the pedaling 
frequency. One way to improve CC on an ergometer cycle is thus to choose the optimal 
cadence related to the power output.  A second way is by increasing muscular efficiency. 
Muscular efficiency 
Strength, Power and Rate of Force Development 
Strength is defined as the maximal force a muscle or muscle group can generate (Komi, 
1992). Power is work (which is the product of force and work distance) divided by time. 
Power is thus the rate of doing work, and is measured in watts (Åstrand and Rodahl, 1986). 
RFD is closely related to power. It is defined as the rate at which a force is developed (Kent 
1994). If the force itself and the time to reach this force, or the time in which this force is 
acting is measured, RFD is measured as Ns-1. If, in a dynamic action, the distance of a 
movement in which force is measured is taken in to account, RFD can be measured as Nms-1.  
The latter is the same as watts, and in this case RFD is the same as power.  
The importance of strength and power in long distance running or cycling would intuitively 
seem small. Each step would in average only account for a small percentage of the maximum 
force production possible in the involved muscle groups. In the final sprint toward the finish 
line, high power production may be of some importance, as is shown in shorter running 
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distances and in soccer. Wisløff et al (2004) demonstrated a strong positive correlation 
between 1RM half-squat strength and sprinting and running performance among soccer 
players. No studies have shown correlation between maximal strength and C, but several 
studies have shown strong correlations between training induced improvements in maximal 
strength and C (Johnston et al. 1997, Paavolainen et al. 1999, Hoff et al 1999, Hoff et al 2002, 
Millet et al. 2002, Østerås et al., 2002, Hoff and Helgerud 2003, McMillan et al 2005, Hoff et 
al 2005, Loveless et al 2005).  
 
Running or cycling velocity 
In 1963, Margaria et al. reported that when energy expenditure is given as functions of 
running speed, the functions appear to be straight lines given net aerobic conditions. They 
argue that since the extrapolations of these lines cross the ordinate very close to the rest 
metabolism, the net energy consumption per distance covered is independent of speed. 
Helgerud (1994) and Slavin et al (1993) reports no change in CR with increasing running 
velocities, whereas Hoff and Helgerud (2003) and Harris et al. (2003) reports slightly 
decreasing CR with increasing running velocities, as is reported by Loveless et al (2005) in CC 
with increasing work intensity. Theoretically, if the intensity of work is high enough and at 
least above LT, measures over a relative short amount of time (i.e. 5 minutes) could show an 
improvement in CR with increasing speed. This is because the relative amount of energy 
released aerobically decreases while the relative amount of energy released anaerobically 
increases. On the other hand, a deterioration of CR with increasing speed is observed. Hunter 
and Smith (2007) found deterioration in CR (approximately 3%) at the end of a one hour 
running session at a speed close to maximal effort among 16 experienced distance runners. 
Also, Collins et al (2000) have found deteriorated CR (approximately 5%) after an intense 
interval session and Thomas et al (1995) report of deterioration in CR (approximately 5%) 
during a submaximal but intense 5-km running session. 
 
Ventilatory demands 
VO2 is measured as a product of the difference between inspired O2 (FIO2) and expired O2 
(FEO2) and the total pulmonary ventilation (VE) (Åstrand and Rodahl 1986). As the 
difference FIO2 – FEO2 represents the arterio-venous oxygen difference (A-V O2-difference) 
(Åstrand and Rodahl 1986), a lower VE at a standard work or velocity should thus be a result 
of either one or two of the following causes: One; the total aerobic demand for performing the 
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work has been lowered, Two; an increase in the A-V O2-difference. Improvements in any 
variable that may improve C will lower CR and thus also VE, since VO2 is a product of the 
difference between FIO2 and FEO2 and VE. Arterial blood flow to exercising muscle occurs 
almost exclusively between muscle contractions (Shoemaker et al 1994). Mean transit time is 
found to positively correlate with A-V O2-difference (Saltin, 1985). If, as a result of a 
decrease in skeletal muscle contraction time, the A-V O2-difference increases, both CR and 
VE may theoretically decrease simultaneously. A high VE is energy demanding in itself. 
According to Aaron et al (1992) the relative oxygen cost of breathing increases from rest up 
to approximately 10% at an intensity corresponding to VO2max. 
 
Franch et al (1998) found that VE decreased on average 11 Lmin-1 following intense interval 
training among male recreational runners. Since individual decrements in VE correlated with 
improvements in CR, Franch et al (1998) suggest that these improvements may account for 
25-70% of the improved CR. It may however, be argued the opposite; that the improvement in 
CR leads to the lower VE. Saunders et al (2004) found no such relation between VE and CR. 
In the study by Saunders et al (2004), elite distance runners improved their CR by 3.3% after 
20 days of simulated moderate altitude exposure, but with no detectable changes in VE 
 
Muscle fiber type distribution 
Both Coyle et al (1992) and Mogensen et al (2006) have reported a close relationship between 
muscle fibre type I and cycling efficiency. Coyle et al (1992) found that the percentage of 
type I fibres in m.vastus lateralis, correlated positively with cycling efficiency.  
 
Contact time
Nummela et al. (2007) have shown a strong negative correlation between contact time (CT) 
and CR among young runners. Further, in a study by Paavolainen et al. (1999), it is indicated 
that better performance in a 10 km time trial is related to higher pre-activation of the working 
muscles accompanied with shorter CTs during the run. However, both Williams and 
Cavanagh (1987) and Kyrolainen et al (2001) have found no correlation between CT and CR.   
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Braking forces 
Vertical and horizontal forces in running 
Heglund and Taylor (1988) have found CR among different sized animals to be determined 
primarily by the cost of activating muscles and of generating a unit of force for a unit of time. 
It is hypothesized by Taylor (1985) that RFD during locomotion, rather than the mechanical 
work that the muscles perform determines CR. Farley and McMahon (1992) and Kram and 
Taylor (1990) have found CR to be proportional to the weight supported, i.e. directly 
dependent on the vertical forces. However, by increasing and decreasing horizontal resistance 
during treadmill running, Chang and Kram (1999) have found horizontal forces to constitute 
more than 33% of the total metabolic cost of horizontal running. When running on track, 
Kyrolainen et al (2001) actually found that the average horizontal forces in the braking phase 
of the step could explain over 80% of CR.  
 
Elastic storage of energy  
CR is of course a reflection of the runner’s technique, which in turn is greatly influenced by 
biomechanical and neuro-muscular recruitment patterns (McMahon 1984, Williams and 
Cavanagh 1987). It has been estimated that the achilles tendon can store 35% of the kinetic 
and potential energy in a step at moderate running speeds, and when the speed increases, 
elastic storage and reutilization of energy seems to become increasingly important (Ker et al. 
1987).  
 
Muscle – tendon stiffness 
According to Alexander (1991), one of the most important roles of the muscle is to modulate 
tendon stiffness to enhance exploitation of elastic energy. A tight muscle-tendon system and 
consequently a high degree of stiffness may thus be advantageous regarding CR, as shown in 
kangaroos by Dawson and Taylor (1973) and in humans after plyometric training (Spurrs et al 
2003). This is supported by the findings from Jones (2002) and Craib et al. (1996) that 
runners who were the least flexible in the lower limbs also had the best CR. Yoon et al (2007) 
have found a negative correlation between ankle joint torque at midpoint and CT in rebound 
jumps. They also found the ankle joint torque to correlate positively with ankle joint stiffness. 
Arampatzis et al. (2006) investigated the influence of muscle-tendon unit’s mechanical and 
morphological properties on CR among runners at three different levels of CR. They found that 
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the patellar tendon among the more economical runners was more compliant at low force 
levels, and that the triceps surae had higher contractile strength, with greater tendon stiffness.  
However, Lichtwark and Wilson (2007) have demonstrated a model predicting an optimal 
degree of muscle-tendon stiffness, suggesting that optimal muscle-tendon stiffness may be 
gait or task dependent and that the highest degree of stiffness thus does not necessarily lead to 
better muscle efficiency. Also, Kerdok et al. (2002) have shown changes in both muscle-
tendon stiffness and CR when manipulating the stiffness of running surface. Kerdok et al. 
(2002) are thus indicating that human runners adjust the level of muscle tendon stiffness 
towards the most optimal degree, to maintain consistent support mechanics on different 
surfaces. 
 
Frequency of movement cycle 
Step frequency in running and cadence in cycling 
Testing different sized animals and scaling for body mass, Heglund and Taylor (1988) have 
shown that mass specific energetic cost of trotting and galloping is almost directly 
proportional to the stride frequency used to sustain a constant speed. According to Cavanagh 
and Williams (1982), most runners naturally choose a stride frequency which minimizes 
metabolic cost. In a study by Hunter and Smith (2007), the self optimized stride frequency 
among 16 experienced runners, which was both the self-selected one and the one expressing 
the best CR, averaged 87 steps per minute. If most runners naturally choose a stride frequency 
which minimizes metabolic cost, there should not be a significant relationship between stride 
frequency and CR. This is in line with Kyrolainen et al. (2001) who did not find significant 
correlations between stride frequency and CR. In cycling, however, it is argued that the self 
selected cadence may be too high to optimize CC (Chavarren and Calbet 1999, Foss and 
Hallen 2004). According to Lucia et al (2001), the preferred cadence among professional 
cyclists during competitions range from approximately 90 RPM to approximately 105 RPM in 
relatively flat courses. In contrast, it is reported that optimal cadence with regard to CC is 
significantly lower than this, but increasing with increasing workload. Chavarren and Calbet 
(1999) have found the most economic cadence to be 60 RPM at several different work 
intensities ranging from 54% to 93% of MAP among competitive road cyclists. Foss and 
Hallen (2004) found the most economical cadence to be 60 RPM at 50 W and 80 RPM at 275 
and 350 W among road cyclists at a national level. Why professional cyclists choose higher 
cadence than the most economic ones is an open question. Previous laboratory studies 
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measuring CC had prior to the study by Foss and Hallen (2004) been carried out during short 
time (3-8 min) submaximal or maximal work stages. Foss and Hallen thus hypotised that elite 
cyclists would perform best at their most efficient cadence during prolonged time trial cycling 
(approximately 30 min). They found that the time results at freely chosen cadence (mean 90 
RPM) were similar to those attained at the most efficient cadence (80 RPM). Marsh and 
Martin (1997) have compared highly trained cyclists and runners and less-trained non-cyclists 
regarding power output on preferred and most economical cycling cadences. They concluded 
that cycling experience and minimization of aerobic demand were not critical determinants of 
preferred cadence. This finding was supported by the results from Hansen and Ohnstad 
(2008), that freely chosen cadence was unaffected by increased loading on the 
cardiopulmonary system and was steady and individual over a 12 weeks period. Hansen and 
Ohnstad (2008) concluded that freely chosen cadence is primarily a robust innate voluntary 
motor rhythm, minimally affected by internal and external conditions.  
 
Leg swing in running and cycling 
A rather controversial aspect concerning CR is that of the metabolic cost of leg swing. Modica 
and Kram (2005) have shown that the cost of initiating and propagating leg swing comprises 
approximately 20% of net CR, by using an external swing assist. In cycling, measures of 
unloaded cycling made by Tokui and Hirakoba (2007) have shown an internal power output 
ranging from approximately 3 W (at 40 RPM) to approximately 90 W (at 120 RPM). The CC 
of unloaded cycling in this study ranged from approximately 0.6 Lmin-1 (at 40 RPM) to 1.6 
Lmin-1 (at 120 RPM). They also found cycling efficiency to be best at a cadence of 80 RPM, 
with a marked reduction of efficiency (19%) from 80 to 120 RPM. They speculate that the 
reduced efficiency at 120 RPM is due to higher levels of internal power output accompanying 
the higher cadence. Based on the studies by Modica and Kram (2005) and Tokui and 
Hirakoba (2007), it seems that the movements of limbs alone may contribute to a significant 
part of the net metabolic cost of running or cycling, and that the higher the frequency, the 
higher the cost. Is it the limb-moving frequency per se (i.e. activation-relaxation rate) that 
increases the cost of movement, or is it the muscle shortening velocity that naturally 
accompanies the frequencies? This problem has been addressed in bicycling by McDaniel et 
al (2002), whose results suggest that it is the muscle-shortening velocity and not the 
activation-relaxation rate that significantly contributes to the net metabolic cost. 
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Other factors interacting as determinants for running and cycling 
economy 
Anthropometric factors
Anderson (1996) lists a number of anthropometric factors that could have a positive effect on 
CR. These includes lower than average height for men, low percentage of body fat, leg 
morphology which distributes mass closer to the hip joint, and narrow pelvis. An inverse 
correlation between calf circumference and CR is shown by Lucia et al (2006). Williams and 
Cavanagh (1987) have found elite female runners to have narrower pelvis than a female 
student population of the same age. Steudel-Numbers et al. (2007) have shown an inverse 
correlation between relative leg length and CR, and Bunc (2000) reports of worse CR 
expressed as JKg-1m-1 with higher percentage body fat among non-trained females. 
Little is reported regarding anthropometric factors and CC. Cyclists at an international level 
seems to be more heterogeneous in body dimensions than long distance runners at the same 
performance level. According to Mujika and Padilla (2001), male professional road cyclists 
represent variable anthropometric values. Although Faria (1992), count air resistance as the 
greatest retarding force affecting cycling, and thus state that the aerodynamics should be a 
major factor influencing CC, anthropometric factors seem to be much less important regarding 
air resistance than are posture and equipment. 
  
Gender
Helgerud (1994) has reported a better CR at velocities equal to LT among female intermediate 
national elite marathon runners than in their performance-matched male counterparts when 
expressing CR per kg body weight raised to the power of 0.75 and metre. This is seemingly 
not in line with results from Daniels and Daniels (1992) who reported male runners to be 6-
7% more economical than women of equal VO2max at set velocities, or with the results from 
Bunc and Heller (1989), who found no significant differences in CR between the sexes. 
However, the results from Daniels and Daniels (1992) and Bunc and Heller (1989) are 
expressed per kg body mass. As females in general differ from the general male in a lower 
total body mass and a higher percentage of fat (Marieb and Hoehn 2007), it is important to 
scale for body mass when comparing genders. In cycling, Yasuda et al (2008) reports no 
gender-specific differences in mechanical efficiency during leg-cycling at intensity relative to 
ventilatory threshold. But according to Weber and Schneider (2000) there may be a gender 
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specific difference in aerobic and anaerobic efficiency, as they have shown untrained women 
to have a lower maximal accumulated oxygen deficit than untrained men after all out cycling, 
even when corrected for active muscle mass. To our knowledge, gender specific difference 
has not been reported in cycling economy. 
 
Variations in Cost of running, Cost of cycling and efficiency 
Inter individual variability in CR is reported by di Prampero et al. (1986) to be 8%, if CR is 
expressed per kg body mass. This is in accordance with results from Margaria et al (1963), 
who found experienced runners to spend 5-7% less energy (measured as kcal per kg body 
weight per hour) compared to nonathletes when running at given velocities. When the 
heterogeneity of a tested variable within a group of subjects increases, so does the inter-
individual variability concerning this variable. Thus, Morgan et al (1995) found a within-
group variation of 20% in CR in four different groups of runners, showing that the elite 
runners had a better CR than the subelite runners, who in turn had a better CR than the good 
runners, and that the good runners had better CR than the untrained subjects. Although there is 
reported relatively large inter individual variability among runners regarding CR, this 
variability may not be equally apparent in cycling. To compare the variability in running and 
cycling is somewhat difficult because of the practice of using economy measurements in 
running and efficiency measurements in cycling. Moseley et al (2004) report no differences in 
CC between world-class and recreational cyclists. On the other hand, gross mechanical 
efficiency has been found to be 1.4% higher in trained cyclists than in untrained cyclists by 
Hopker et al (2007). This is seemingly a smaller difference than what has been shown in CR 
between trained and untrained runners (Margaria et al 1963, Morgan et al 1995). Since the 
difference in CC is expressed as a per cent of a per cent (the latter being approximately 22%), 
the 1.4% difference reported by Hopker et al (2007) is in reality approximately 1.4  (100/22) 
% = 6.4%, and thus in line with what is reported in running. As C does not increase in the 
same proportion as body weight, part of the variation in CR in published experiments will be 
due to weight differences. Allometric scaling seems to reveal smaller inter-individual 
differences in CR. Helgerud (1994) typically show SD’s of approximately 5% between 
marathon runners when expressing CR as oxygen cost per kg bodyweight raised to the power 
of 0.75 and metre. The variation in CR between soccer players are also shown to be relatively 
small. Hoff et al. (2005) testing 36 professional players showed CV to be less than 5%. This is 
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in line with the results from Helgerud et al. (2001), Helgerud et al. (2003) and Hoff and 
Helgerud (2003)  
 
Training induced changes in Cost of running and Cost of cycling 
Adaptations to endurance training 
In a controlled intervention study by Helgerud et al. (2001), an improvement of 6.7% in CR 
among junior soccer players after eight weeks of interval running training, is reported. A 
3.7% improvement is shown from a similar intervention in a soccer Champions League team 
where the training mode was treadmill running (Helgerud et al. 2003). Both interventions 
were followed by an improvement in VO2max of approximately 10%.  The CR improvement is 
in accordance with results from Billat et al. (2002). They found improved CR expressed as 
time to exhaustion at running velocities representing 90% and 95% VO2max after four weeks 
of interval training at MAS. This may indicate that high intensity interval training may 
increase race specific CR among athletes competing at velocities representing approximately 
the runners VO2max (3000m and 5000m).  
 
As CR is an expression of running technique it should be an obvious consequence from 
increasing the volume of running that running technique is improved. This is elegantly shown 
in McMillan et al. (2005) where soccer players used the same intervention with high intensity 
aerobic interval training as used by Helgerud et al (2001, 2003), this time only with the 
difference that the endurance training intervention was running with the soccer ball in a track 
including changes in direction and pace. The results from this intervention showed the same 
10% improvement in VO2max, but no change in running economy measured on the treadmill. 
For inexperienced runners an improvement in CR from increased amounts of running or 
walking should be expected. The same should thus apply to cycling efficiency. This is shown 
in an intervention study by Hintzy et al (2005) where nine previously sedentary women 
improved gross efficiency by 11% after 6 weeks of low intensity cycling endurance training. 
Competitive runners would probably not improve CR much from increased volume of 
running, as it already constitutes almost all of their training. However Scrimgeour et al. 
(1986) found CR to correlate highly with weekly running distance among marathon and ultra 
marathon runners. At 13 km  h-1 the athletes running more than 100 km per week exhibited 
more than 15% better CR than those running less than 60 km per week. Of course as the study 
by Scrimgeour et al (1986) is not an intervention, one can not conclude that it is the higher 
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amount of km covered per week that leads to the better CR. It may be that the better CR leads 
to the higher weekly training distance. A person with 15% lower cost of running will spend 
15% less energy by covering a given distance, and should thus be able to run longer. 
Adaptations to strength training  
All strength training performed over an extended period of time will lead to some hypertrophy 
(Kraemer and Ratamess 2004). The amount of hypertrophy will depend on several factors. 
Two important determining factors seem to be type of strength training and muscle fibre type 
distribution (Kraemer and Ratamess 2004). Traditional hypertrophy training consisting of 5 -
12 repetitions maximum involves contractile protein damage and connective tissue damage as 
well as metabolic stress. Studies indicate greatest hypertrophic response when the maximum 
number of repetitions per set exceeds 5 but are below 12 (Atha 1981, Tesch 1988, Campos 
2002). The hypertrophic response is most likely due to an increase in myofibril cross-
sectional area (Goldspink 1992). 
 
Neural adaptations to strength training includes both selective activation of motor units, 
increased recruitments of motor units, increase of motor unit discharge rate, motor unit 
synchronization and co-contraction regulation of antagonists (Behm 1995). These neural 
adaptations have in common an increased ability of activation and regulation of motor unit 
signals as a result of external and to some extent internal demands (Kraemer and Ratamess 
2004, Gandevia 2001). Based on the classic force-velocity curve of Hill (1938), it has been 
debated whether or not neural adaptations are subject to velocity specific strength training. 
While several authors (Coyle et al 1981, Kanehisa and Miyashita 1983, Kaneko et al 1983) 
have reported high velocity strength training to increase high velocity strength more than low 
velocity training, Behm and Sale (1993) have demonstrated that intent of high velocity in 
strength training produces almost the same high velocity strength response. As discussed in 
Hoff (2001), the recruitment pattern, rather than the actual movement velocity seem to be the 
crucial factor for the neural adaptations associated with strength training. This is also 
elegantly shown in the study by Hoff and Helgerud (2003). MST with high loads and focus on 
maximal mobilization in the concentric phase in a group of soccer players showed an increase 
in RFD of 52.3 %. Strength training has also been reported to increase muscle – tendon 
stiffness (Kerdok et al. 2002), and tendon cross-sectional area (Kongsgaard et al. 2005).  
Hypertrophy leading to a significant increase in muscle physiological cross-sectional area will 
cause an increase in total body weight (Kraemer and Ratamess 2004). This weight gain may 
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prove negative on an athletes running performance, since the athlete has to transport and 
support his own body weight while running. Also in cycling weight gain may prove negative 
on performance, at least when climbing hills. When MST is performed with high loads, few 
repetitions and with focus of maximal concentric mobilization, improvements in maximal 
strength have been reported without any changes in body weight (Hoff et al., 1999, Hoff et 
al., 2002, Østerås et al., 2002, Hoff and Helgerud 2003, Hoff et al. 2005, McMillan et al. 
2005).  
 
MST performed without concurrent endurance training has previously been reported to impair 
aerobic endurance performance. According to Tanaka & Swensen (1998), training of MST 
without concurrent endurance training will reduce relative mitochondrial density, capillary 
density, oxidative enzyme activity, and intramuscular fatty acid storage. Gettman & Pollock 
(1981) found that MST performed over eight to nine weeks resulted in a 0.5 to 9.0% decrease 
in VO2max among their subjects. It is likely that the reduced densities are only relative, due to 
muscular hypertrophy from MST. The reduced performance could also by large be due to 
reduced volume of endurance training. On the other hand, intense endurance training without 
concurrent MST seems to impair the capacity to perform maximal power output. Dudley and 
Fleck (1987) have shown reduced vertical jump height after an increased amount of 
endurance training, and also increased vertical jump height when the amount of endurance 
training is reduced. Performed as a minor part of the total training volume, and when 
combined with endurance training, MST does not seem to impair the development of VO2max. 
When comparing three different training groups, one training only MST, one only endurance 
training, and one a combination of the former two, Dudley & Fleck (1987), found no 
significant differences in VO2max improvements between the endurance group and the 
combination group. This is in accordance with results from McCarthy et al. (1995), who 
performed a similar study. Several studies have reported improved work economy after MST 
as a supplement to endurance training, especially when employing strength training designed 
to enhance strength through neuromuscular adaptations rather than hypertrophy (Hoff and 
Almåsbakk 1995, Hoff et al. 2002). C at a standardised workload in double poling cross-
country skiing improved by 10 - 20% after MST using a modified pull-down apparatus in 
three separate experiments (Hoff et al., 1999, Hoff et al., 2002, Østerås et al., 2002). Hoff et 
al. (1999) points at the relative reduction in force and high improvement in rate of force 
development and thus reduced contraction time as a determining factor for improved 
circulation. Østerås et al. (2002) conclude that the improved exercise economy can be partly 
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explained by a specific change in the force-velocity relationship and the mechanical power 
output. Regarding running economy Hoff and Helgerud (2003) have demonstrated an 
improvement in CR among soccer players by 4.7%, expressed as ml·kg-0.75·m-1, after eight 
weeks of MST. McMillan et al. (2005) using the same intervention have found similar 
improvements. A strength training intervention using the same intervention with experienced 
distance runners competing in orienteering and cross-country skiing was carried out by Hoff 
et al. (2005), and have shown a 5% improvement in CR when running at 10% inclination and 
an 8% improvement in CR when running at 20% inclination, indicating that relative load is an 
important factor for running economy. Paavolainen et al. (1999) also claim that strength 
training changes running economy, but both increased body weight, multiple interventions 
and increased running that also improves VO2max makes it problematic to detect the cause and 
relationship. In a study by Hansen et al (2007), 14 non-cyclists performed strength training 4 
days per week for 12 weeks. They report a 20% improvement in 1 RM squats, accompanied 
by a decrease in cadence of 8 RPM at a cycling intensity of 37% of VO2max, and a 3% 
improvement in CC at the same intensity. Marcinik et al (1991) reported improvements in 
cycling in LT brake power and time to exhaustion at 75% of MAP after 12 weeks of strength 
training, indicating an improvement in CC.  
 
MST as a supplement to endurance training is shown to improve CR. However, no studies 
have shown that the subjects with the highest 1RM results have the best CR. The question thus 
arise: what are the mechanisms behind the shown improvements in CR? Theoretically, both an 
increase in RFD (Hoff and Helgerud, 2003), a more optimal activation of motoneurons and 
muscle fibers (Gandevia 2001), an optimizing of muscle-tendon stiffness (Kerdok et al, 2002) 
and pre-activation of working muscles (Paavolainen et al, 1999), a shorter contact time (CT) 
(Nummela et al. 2007) as a result of MST may improve CR, possibly together with other 
factors. Central changes affecting muscle activation may occur both at a supraspinal as well as 
at a spinal level (Gandevia 2001). Further investigations regarding these variables are needed 
to gain a more thorough understanding of the effects of MST on CR.  
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Rationale and aims of the experiments
Long distance running and cycling are activities where energy released aerobically is 
predominantly determining the performance (Åstrand and Rodal 1986; Medbø and Tabata 
1989). Running or cycling economy is considered one of the three major factors accounting 
for inter-individual variance in aerobic endurance performance (Pate and Kriska 1984). The 
main aim of this thesis is to gain further knowledge about long distance running and cycling 
economy measured as the oxygen cost of running and cycling (CR and CC) by investigating: 
 
 Determining factors for CR (study IV). 
 The reliability of an incremental test protocol for calculating CR at different     
velocities and intensity levels (study II). 
 The intensity levels to which CR is reliably calculated (study II). 
 The influence of lactic acid concentrations on CR (study I). 
 The effect of maximal strength training on CR and CC (studies III and V) 
 
And further, to calculate from the results in the five studies: 
 
 The relative importance of CR and CC on aerobic endurance performance 
 Possible gender differences in CR 
 
Paper I: 
Lactic acid accumulation is associated with development of muscle fatigue during exercise 
(Fitts 1994), and is thus considered to be negatively correlated to endurance performance 
(Åstrand and Rodahl 1986, Pilegaard et al 1999). As CR deterioration seems to be related both 
to an increasing intensity and an increasing duration (Sproule 1998), the main aim of study I 
is to investigate if increased lactate levels influence CR during endurance running. 
Paper II: 
CR is often measured as the oxygen cost per meter of running. Helgerud (1994) and Slavin et 
al (1993) reports no change in CR with increasing running velocities, whereas Hoff and 
Helgerud (2003) and Harris et al. (2003) reports slightly impaired CR with increasing running 
velocities. If CR is to deteriorate with increasing intensity and La-b, there should be an upper 
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limit regarding intensity up to which CR is a reliable measure of running economy. The main 
aim of study II is to find this limit, and further to evaluate the reliability of an incremental 
protocol for assessing CR. Since Helgerud (1994) has shown that female marathon runners 
have better CR than their performance matched male counterparts, a secondary aim in study II 
is to investigate potential differences between genders in CR. 
Paper III: 
In both cross-country skiing (Hoff et al., 1999, Hoff et al., 2002, Østerås et al., 2002), soccer, 
(Hoff and Helgerud 2003, McMillan et al. 2005), and uphill running (Hoff et al. 2005), MST 
has been shown to improve CR. Also in distance running, CR is improved as a result of MST 
(Millet et al. 2002, Paavolainen et al. 1999, Johnston et al. 1997). But neither Millet et al. 
(2002), Johnston et al. (1997) nor Paavolainen et al. (1999) have scaled for body weight when 
reporting the CR results. In these three studies several different strength training or ballistic 
exercises were used, which makes it difficult to identify the cause of improvements. In study 
III the main aim is to investigate if MST improves CR for well trained runners when running 
at 1.5% inclinations. A secondary aim in study III is to investigate if MST has an effect on 
tMAS.  
Paper IV: 
Conley and Krahenbuhl (1980) and Helgerud (1994) have shown inter-individual variations in 
CR at a standard running velocity. The causes of this variability are not well understood, but it 
seems likely that anatomical traits, mechanical skill, neuromuscular skill and storage of elastic 
energy are important factors (Pate and Kriska 1984). Also, MST interventions have improved 
CR (Hoff and Helgerud 2003, McMillan et al. 2005, Hoff et al. 2005, Millet et al. 2002, 
Paavolainen et al. 1999, Johnston et al. 1997). The purpose of study IV is to identify possible 
causes of inter-individual variations in CR, and also to possibly identify some of the factors 
involved when MST affects CR. Thus, the aim of this study is to detect possible relationships 
between anthropometrical measures, vertical and horizontal ground reaction forces, stride 
frequency, maximal strength in lower extremities, CT and CR among elite endurance athletes. 
 
Paper V: 
No studies have shown correlations between maximal strength and CC, but several studies 
have shown strong correlations between training induced improvements in maximal strength 
and work economy (C). In cross country skiing (Hoff et al., 1999, Hoff et al., 2002, Østerås et 
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al., 2002), soccer, (Hoff and Helgerud 2003, McMillan et al. 2005), and uphill running (Hoff 
et al. 2005), MST has been shown to improve C in only eight weeks. Likewise, Millet et al. 
(2002), Paavolainen et al. (1999) Johnston et al. (1997) have found improvements in CR after 
MST interventions. Loveless et al (2005) have shown that maximal strength training improves 
CC in previously untrained subjects. The aim of this study is thus to assess to what extent 
maximal strength training with emphasis on neural adaptations, as a supplement to endurance 
training, affect CC and work efficiency (WE) among competitive road cyclists. A secondary 
aim in study v is to investigate if MST has an effect on tMAP.  
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Methods
Subjects
Subject characteristics are presented in table 1. 
 
Table 1    Subject characteristics (N = 63) 
                 Study I Study II Study III Study IV Study V 
N
(Interv. + control) 
 
7 (7+0) 
 
15 (15+0) 
 
17 (8+9) 
 
11 (11+0) 
 
13 (8+5) 
     
Level Elite Moderately to well 
trained 
Well trained Elite Well trained 
Age  in Years 
(Mean  SD) 
 
23.0 3.0 
 
30.0  9.2 
 
28.610.1 
 
21.43.9 
 
32.99.0 
     
Gender  
(Males + Females) 
 
7+0 
 
9+6 
 
9+8 
 
11+0 
 
10+3 
Sport (N) 
 
Orienteering (4) 
CC skiing (3) 
 
 
Dist. running (8) 
CC-country skiing (4) 
Triathlon (3) 
 
Dist. running (17) 
 
 
Dist. running (2) 
CC skiing (5) 
Orienteering (2) 
Biathlon (2) 
 
Road Cycling (13) 
N, number of subjects. Interv, intervention group. Control, control group. SD, standard deviation. CC skiing, 
cross – country skiing. Dist. Running, distance running. 
 
Testing procedures  
In studies II, III and V ergo-spiro-metrical data were collected using the metabolic test 
system, Sensor Medics Vmax Spectra (Sensor Medics 229, Yorba Linda, California, USA). 
Lactate measurements were performed using an Arcray Lactate Pro LT-1710 analyzer, venous 
whole blood (Arcray Inc. Kyoto, Japan) and heart rates were measured using Polar s610 heart 
rate monitors (Kempele, Finland). The treadmill used in studies II and III was a Woodway 
PPS 55sport (Waukesha, Germany), and the ergometer cycle used in study V was a Lode 
Corival 906900 (Lode, Groningen, Netherlands) modified at Department of Sport and 
Outdoor Life Studies, Telemark University College (Bø, Norway) to fit competitive cyclists. 
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Figure 1   Subject on the ergometer cycle, connected to the metabolic test system 
Picture from study V. The subject has approved the use of the picture in this thesis.  The ergometer cycle is a 
modified Lode Corival 906900. The metabolic test system is a Sensor Medics Vmax Spectra.  
 
In studies I and IV ergo-spiro-metrical data were collected using the portable metabolic test 
system Cortex Metamax II (Cortex, Leipzig, Germany). Heart rate was measured using a 
Polar S410, (Kempele, Finland). The treadmill used in these two studies was a Technogym 
RunRace (Gambettola, Italy). Lactate measurements in study I were performed using an YSI 
1500 Sports Lactate analyzer (whole blood) (Yellow Springs Instruments CO, USA). 
The RFD data in study III and V were collected using the Muscle Lab system (Ergo test 
Technology, Langesund, Norway). Body fat was measured in study IV with a Lange skin 
calliper, (Beta Technology, Santa Cruz, CA, USA). Measurements of vertical forces in study 
IV were made by Pedar-X contact soles from (Novel, Munich, Germany). To measure 
horizontal forces in this study, the front of the treadmill was placed upon a force platform, 
Bioware (Kistler, Switzerland), with the rear end of the mill hanging freely in a special device 
designed for this purpose at the Department of Circulation and Imaging, Faculty of Medicine, 
Norwegian University of Science and Technology. CT and stride frequency were also 
measured using this system. 
Assessment of LT – In studies I, II and III, the subjects started at an individual warm-up 
velocity corresponding to approximately 60% VO2max, which was maintained for either 5 or 
10 minutes. Every five minutes from there on, the speed was increased by 1.5 km·h-1. The 
protocol terminated at more than 1.5 km·h-1 above the subjects’ lactate threshold (LT). LT 
was defined as the warm up La-b value (i.e. measured after the lowest velocity) + 1.5 
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mmol·L-1. This is the protocol proposed by Helgerud et al. (1994). In study V, the subjects 
started at an individual warm-up intensity corresponding to approximately 40-50% VO2max, 
that is between 100 and 200W, which was maintained for either 5 or 10 minutes. Each of two 
subsequent five minute steps from there on, the brake power was increased by either 25 or 
50W, after subjective evaluation. Every five minutes after the first two steps, the brake power 
was increased by 10 to 25W, until the protocol terminated at more than 25W above the 
subjects’ LT, defined as the warm up La-b value (i.e. measured after the lowest velocity) + 
1.5 mmol·L-1, as for running. Note that for the studies where Arcray Lactate Pro LT-1710 
analyzer was used (studies II, III and V), 1.5 mmol·L-1 equals 2.3 mmol·L-1 as the Lactate Pro 
measures 40% higher values than the YSI. 
Assessment of VO2max – VO2max was tested in all studies, by use of an incremental protocol. In 
studies I to IV, all subjects were running at 5 % inclination throughout the test. In study V, the 
subjects used the same ergometer cycle as previously described, and cycled at a self-selected 
cadence. In all five studies, the subjects started at a velocity or intensity representing 
approximately their individual LT intensity level. Every 30 or 60 seconds, the speed or power 
was increased by 0.5 or 1.0 kmh-1 or by 10 or 25W, based on the subjective evaluation of the 
test leader. The test terminated at voluntary exhaustion by the subjects. HR ( 98 % HRmax), R 
( 1.05) and La-b ( 8.0 mmolL-1) values, as well as a possible flattening of the VO2 curve, 
was used to evaluate if VO2max was obtained. Measurements of VO2 values were made every 
10 seconds when the Metamax II was used (studies I and IV) and every 20 seconds when the 
Vmax Spectra (studies II, III and V) was used. VO2max was computed as the average of the 
three highest (Metamax II) or the two highest (Vmax Spectra) VO2 values at the end of the 
test. 
Assessment of CR, CC, MAS and MAP – CR or CC at set velocities were calculated as the 
average of four (three with the Vmax Spectra) VO2 values between 3.30 min and 4.30 min, 
and divided by running velocity or brake power at each 5 min work in study II, III and V. In 
study I, CR at set velocities was calculated as the average of four VO2 values between 4.00 
min and 4.30 min, and divided by running velocity. At relative intensities such as 70% 
VO2max (study II, III and V); linear regressions between velocity or brake power and VO2 for 
each subject provided both the VO2 and the velocity or brake power values needed. By use of 
the linear regression equation, velocity or brake power at a certain per cent of VO2max could 
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be calculated. An example is presented in figure 2. MAS was calculated on the basis of the 
submaximal measurements and VO2max, and was defined as the velocity point where the 
horizontal line representing VO2max meets the extrapolated linear regression representing the 
sub maximal VO2 measured in the LT assessment. MAP was calculated using the same 
method, only using brake power (W) instead of velocity. Further, in study I, the subjects were 
also tested for CR at LT velocity with initial La-b of either 3 mmolL-1 or 5 mmolL-1. After a 
VO2max test, four of the subjects in study I were randomly selected to run at a lower intensity 
in order to decrease La-b values to target 3 mmolL-1. When reaching this target, they ran at 
LT velocity for 5 minutes with continuous registration of VO2 and HR. Thereafter, the speed 
was increased in order to increase La-b values to target 5 mmolL-1. When reaching this 
target, they ran at LT velocity for 5 minutes with continuous registration of VO2 and HR. The 
same procedure was repeated for the three remaining subjects, but in the opposite order, i.e. 
starting with a La-b value of 5 mmolL-1. CR was calculated from VO2 measures and running 
velocity as described above. 
 
Figure 2 Linear regression between running velocity and VO2. 
The linear regression equation in figure 2 is: y = 3.9393x + 2.7963.  R = 0.9997. VO2max for this runner is 69.2 
mlkg-1min-1. 70 % VO2max for this runner is 48.4 mlkg-1min-1. From the equation, the corresponding velocity 
is 11.7 km·h-1, which equals 195 m·min-1. CR expressed as mlkg-1m-1 is thus 0.284 mlkg-1m-1. MAS is the 
velocity point where the horizontal line representing VO2max meets the extrapolated linear regression 
representing the sub maximal VO2 measurements. Here represented by a velocity of 16.9 km·h-1. 
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Assessment of Maximal strength (1RM) and RFD – Both in studies III, IV and V, half-squat 
was used as the exercise in the assessment of 1RM and RFD. Only 1RM was tested in study 
IV. Free weights were used in study III, whereas a leg-press machine was used in study IV 
and a Smith-machine was used in study V. Each lift was performed with a controlled slow 
eccentric phase, a complete stop of movement for approximately one second in the lowest 
position, followed by a maximal mobilization of force in the concentric phase ensuring a 
follow up by use of plantar flexors. In study III and V, the measurements of lifting time, 
distance of work and thus RFD were performed using the Muscle Lab system (Ergo test 
Technology, Langesund, Norway). This test started using 10 reps at a weight load assumed to 
be approximately 50% of 1RM. After 3 minutes of rest: 5 reps at app 60% 1RM. After 
another 3 minutes rest: 3 reps at app 70% 1RM, then 3 minutes of rest before 1 rep at app 
80% 1RM. From there on: 1 rep at a weight load increased by 2.5 kg – 5 kg from the 
subsequent lift, followed by 5 minutes of  resting, until reaching 1RM. The time spent in each 
lift, as well as the work distance was measured. As the external force of each lift is 
represented by the weight of the lifted bars, the rate of force development (RFD) can be 
calculated and expressed as N·m·s-1 or watt (W). In study IV, The test started with one 
repetition at approximately 70% of predicted one repetition maximum (1RM). The loads were 
gradually increased (approximately a total of 10 lifts) until the athlete could no longer manage 
to overcome the load. 
 
Assessment of peak average horizontal and vertical forces during running – In study IV, after 
five minutes warm up, the subjects ran for one minute at 15 kmh-1 on a level treadmill. They 
were wearing contact soles, and the treadmill was adjusted as described previously. Average 
peak force (APF) for both vertical and horizontal forces was the average of peaks over a 10 
seconds period. CT and stride frequency were calculated from the force measurements, 
running velocity and time. An example of one step force characteristics is presented in figure 
3. 
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Figure 3   Force characteristics in one step from one runner 
Figure from study IV. This is an example of the force characteristics in a single step by one of the runners.  
Force is displayed on the vertical axis, and time is displayed on the horizontal axis. N, Newton. S, seconds. 
The axis on top represents vertical forces, while the axis at the bottom represents horizontal forces. 
Training procedures  
Strength training intervention – In studies III and V, the intervention group completed an 8 
week intervention whereas the controls completed an 8 week normal training period. During 
these weeks, both the intervention group and the control group were thus performing their 
running or cycling training as normal. To control the training, each subject had to report 
weekly the exact amount of time spent in the different training intensity zones 60-85%, 85-
90% and 90-95% of HRmax.  In addition to their normal endurance training, the intervention 
group completed a MST session consisting of 4 sets of 4RM half-squats, divided by 3 minutes 
of rest between each, three days a week. Each lift was performed with a controlled slow 
eccentric phase, a complete stop of movement for approximately one second in the lowest 
position, followed by a maximal mobilization of force in the concentric phase ensuring a 
follow up by use of plantar flexors. Every time a subject managed to do 5 repetitions during a 
set, 2.5 kg were added for the next set. The subjects used free weights in study III, and a 
Smith-machine in study V. Guidance and instructions were given all participants during the 
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training period, and training logs for the MST were made by all participants in the 
intervention groups.  
Statistical analysis 
All statistical analyses were performed using the software program SPSS, version 13.0 
(Statistical Package for Social Science, Chicago, USA). In all cases, p0.05 was taken as the 
level of significance in two-tailed tests. Descriptive statistical analysis was made to display 
means and standard deviations (SD). To compare means, paired T-tests and independent 
samples T-tests were used in studies I, II and III. Non-parametric statistics (Wilcoxon`s and 
Man Whitney) were used in paper V.  In paper II, changes in CR across different intensity and 
velocity levels were analyzed by General Linear Model. The data were tested for normal 
distributions using Quantile-Quantile (QQ) plots. Correlations were calculated by the Pearson 
correlation test.  
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General summary of experiments 
 
Paper I: High blood lactate levels deteriorates running economy in elite endurance athletes 
7 elite endurance athletes (4 orienteers and 3 cross country skiers) participated in this study. 
The athletes were first tested for CR at 10 kmh-1 and for LT on a treadmill with 1.5% 
inclinations, and for VO2max at 5.0% inclinations. They were then tested for CR at their LT 
velocity with a pre La-b of either 3 mmolL-1 or 5 mmolL-1, followed by a crossover of the 
lactate levels. The study shows that CR deteriorated (5.5%) when pre La-b was raised from 3 
mmolL-1 to 5 mmolL-1. La-b was found to decrease (31.2%) during the run at LT velocity 
with a pre La-b of 5 mmolL-1. This is a strong indication of an underestimation of LT 
velocity. Also during the running session at LT velocity with a pre La-b of 3 mmolL-1, La-b 
was found to decrease significantly (21.8%). In conclusion, increased lactate levels are 
accompanied by deteriorating running economy. 
 
Paper II: Are there differences in running economy at different velocities? 
15 moderately to well trained (9 male and 6 female) endurance athletes participated in this 
study. CR, heart rate and blood lactate was measured during 5 minutes runs at velocities 
ranging from 8.0 to 17 kmh-1, representing intensities ranging from 60% to 90% of VO2max 
on two different days. The athletes were also tested for LT, VO2max, MAS and tMAS. There 
was found no differences in CR between the different relative velocities or the different set 
velocities for the male or the female athletes. All athletes reached their VO2max while running 
to exhaustion at MAS. The females showed significantly lower VO2max (25.3%) but 
significantly better running economy (9.8%) than the males. In conclusion, running economy 
measured as oxygen cost of running is reliably calculated up to running intensities 
representing 90% of VO2max. An incremental protocol for measuring VO2 at different 
velocities does not affect the reliability of these measurements. 
  
Paper III: Maximal strength training improves running economy in distance runners. 
17 well trained (9 male and 8 female) runners were randomly assigned into either an 
intervention or a control group. The intervention group (4 males and 4 females) performed 
half-squats, 4 sets of 4RM, three times per week for 8 weeks, in addition to their regular 
endurance training. The control group continued their normal endurance training during the 
same period. The intervention manifested significant improvements in 1RM (33.2%), RFD 
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(26.0%), CR (5.0%), and time to exhaustion at pre test MAS (21.3%). No changes were found 
in VO2max or BW. The control group exhibited no changes from pre to post values in any of 
the parameters. In conclusion, maximal strength training for 8 weeks improved CR and 
increased tMAS among well trained long distance runners, without change in VO2max or BW. 
 
Paper IV: Running stride peak forces inversely determines running economy in elite runners  
11 elite endurance athletes participated in this study. 1RM in half-squat leg press, VO2max, CR, 
vertical and horizontal external forces while running, BW, height, leg length, calf 
circumference, hip width, and body fat percentage was examined. 3 km best time results 
attained during the last season were collected. None of the force measures correlated 
significantly alone with either 3000m performance time or CR. However, when put together, 
as the sum of horizontal and vertical eccentric and concentric peak forces (APFtotal) a 
significant inverse correlation (p0.05) was found both with 3000m performance (R=0.71) 
and CR (R=0.66). Moderate inverse correlations were found (p0.05) between CR and body 
height (R=0.61) and between CR and body fat percentage (R=0.62). 
 
Paper V: Strength training improves cycling economy.
16 competitive road cyclists (12 male and 4 female) were randomly assigned into either an 
intervention or a control group. 13 (10 male and 3 female) cyclists completed the study. The 
intervention group (7 males and 1 female) performed half-squats, 4 sets of 4RM, three times 
per week for 8 weeks, in addition to their regular endurance training. The controls should 
continue their regular endurance training during the same period. The intervention manifested 
significant improvements in 1RM (14.2%), RFD (16.7%), CC (4.8%), WE (4.7%) and tMAP 
(17.2%). No changes were found in VO2max, BW or cadence. The control group improved WE 
by 1.4%, but there was a significant difference in improvements between the intervention and 
the control group. In conclusion, maximal strength training for 8 weeks improved CC and WE 
and increased tMAP among competitive road cyclists, without change in VO2max, cadence or 
BW. 
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Discussion across the experiments 
General discussion 
Paper I demonstrated that CR deteriorates with increased La-b. Previous studies have 
reported deterioration in CR of 3-5% after intensive training (Collins et al 2000, Thomas et al 
1995, Hunter and Smith 2007), but it is unclear whether or not these results are accompanied 
by increased levels of La-b. As in papers II, III and IV, inter-individual variability in CR 
expressed as mlkg-0.75m-1 was found to be approximately 5-6%. Previously, Helgerud (1994) 
has found a variability of approximately 5% among marathon runners when expressing the CR 
as VO2 mlkg-0.75m-1. These values are also in agreement with those found among soccer 
players (Helgerud et al 2001, Helgerud et al 2003, Hoff and Helgerud 2003, Hoff et al., 2005). 
No significant difference in CR when the subjects were running at 10 kmh-1 compared with 
LT velocity (paper I) was observed. This finding was supported in paper II, where no 
significant differences in CR between the different relative velocities or the different set 
velocities were found for neither male nor female athletes, up to 90% of VO2max. These results 
are in line with previous results from di Prampero et al. (1986) and Helgerud (1994), but not 
in agreement with the results from Daniels & Daniels (1992) who found worsened CR when 
relative running intensity increased in the area between 70% and 100% VO2max. Paper II also 
demonstrated a significantly better CR (approximately 10%) and a significantly poorer VO2max 
(approximately 25%) among the females than among the males. The two genders were not 
matched for performance. Study III also contained both male and female subjects. When 
combining CR results from these two studies, there is still a significantly (p0.01) better CR 
among the female subjects (0.663  0.039 mlkg-0.75m-1) than among the male subjects (0.724 
 0.057 mlkg-0.75m-1). Since men and women were not matched for performance, we have no 
explanations as to why the women had better CR than the men. However, the women had 
lower VO2max (mlkg-0.75m-1) than the men, which was also the case in the study by Helgerud 
(1994). The incremental protocol evaluated in study II, was found not to affect the reliability 
of VO2 measurements at different intensity levels in that study. The protocol was thus used in 
parts of study III and study V. 
 
In paper II we also demonstrated that all the subjects reached their VO2max when running to 
exhaustion at MAS. The protocol for assessing MAS was thus repeated in study III, and for 
MAP in study V. All subjects reached their VO2max when running or cycling to exhaustion at 
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MAS or MAP. tMAS was in paper III shown to increase significantly (21.3%) as a result of a 
better CR (5.0%), due to eight weeks of MST. The better CR after MST is in agreement with 
previous results by Hoff and Helgerud (2003), Millet et al. (2002), Paavolainen et al. (1999) 
and Johnston et al. (1997). This was supported in study V regarding cycling, expressing an 
improvement of 4.8% in CC accompanied by an improvement of 17.2% in tMAP. In cycling 
unlike running, vertical movement of the centre of mass is minimal, unless riding uphill. The 
braking forces are first and foremost represented by the resistance to the cyclist and bicycle 
moving forward, or by the artificial braking of the flywheel if riding an ergometer cycle, and 
transferred to the pedals. Consequently elastic storage of energy that plays an important role 
in running economy should logically not be as important in cycling. Our results may indicate 
that an improvement in muscle-tendon stiffness leading to an improvement in elastic recoil is 
not the main adaptation from MST in these two studies. 
 
Based on the papers I, II and II, and previously published studies regarding CR, we sought to 
find some determining factors for CR in study IV. In paper IV, we demonstrated that APFtotal 
was found to be negative related to CR and 3000m running performance. None of the force 
measures correlated, however, significantly alone with either performance or CR. APFtotal 
gave a significant negative correlation (p0.05) both with 3000m performance (R=0.71) and 
CR (R=0.66). The only relationships observed between anthropometric variables and CR were 
moderate inverse correlations between CR and body height (R=0.61) and between CR and 
body fat percentage (R=0.62). This is probably because the subjects participating in this study 
were relatively homogenous regarding anthropometric variables. As in studies III and V, there 
was no direct relationship between 1RM half-squat and CR. No correlations between 1RM and 
CT or time to peak force in study IV were observed. In previous intervention studies as well 
as in study III and study V, MST improved CR and CC by approximately 5%. The finding in 
study IV thus supports Hoff and Helgerud (2003) and Østerås et al (2002) that neuromuscular 
rather than hypertrophic responses to the MST is the main source of the reported 
improvements in these interventions.  
Cost of running and cycling 
In the four studies concerning CR in this thesis, we found inter-individual variations between 
6.3% (study I) and 7.0% (study IV). If results from all studies are combined, mean CR was 
0.691  0.042 mlkg-0.75min-1, with an inter-individual variation of 7.3%. The variation of 
means between the different studies was 5.4%. These results are in accordance with results 
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from previous studies on running where body weight has been scaled (kg0.75), like  Helgerud 
et al. (2001), Helgerud et al (2003), Hoff and Helgerud (2003) and Hoff et al. (2005). 
 
Table 2           Physical and physiological factors in paper I to V 
Paper
 
I (n=7) 
 
II (n= 15) 
 
III (n=8) 
 
IV (n=11) 
 
V (n=8) 
Type of study 
 
Intervention 
(Incr. La-b) 
 
Intervention 
(Incr. Kmh-1) 
 
Intervention 
(8 weeks MST) 
 
Descriptive 
 
 
Intervention 
(8 weeks MST) 
VO2max      
   mlkg-1min-1 80.7 2.7 65.3 7.0 61.4 5.1 75.8 6.2 63.4 6.0 
   mlkg-0.75min-1 235.0 8.8 190.0  17.8 170.6  15.3 220.2  7.0 185.0  15.4 
   mlkg-0.67min-1 331.0 18.6 266.5 23.7 237.5  19.9 310.2  15.3 259.7 24.7 
CR      
   mlkg-0.75m-1 0.7040.044 0.7250.040 0.6790.036 0.652  0.043  
CC      
   mlkg-0.67W-1     0.840 0.065 
CR or CC Change (%) 5.5  0.4** 0.7  0.8 -5.0  0.9*  -4.8  1.5* 
LT      
   % VO2max 824 834 834  775  
   kmh-1 16.4 0.8 12.81.0  12.9  1.4   
1RM      
   kg   73.4  20.5  
(free weights) 
247.3  52.7 
 (leg press) 
155.0 40.6  
(Smith-machine) 
   Change (%)   33.2  1.1**  14.2 2.2* 
RFD      
   W   466.7  163.2#   832.6 171.6#
   Change (%)   26.0  3.3**  16.7 6.6* 
Values are Mean  SD. VO2max, maximal oxygen uptake. CR, oxygen cost of running. CC, oxygen cost of cycling. 
LT, lactate threshold. 1RM, one repetition maximum in half-squat. RFD, rate of force development in half-squat. 
Incr, increase in. MST, maximal strength training. La-b, blood lactate concentration. Min, minutes. M, metres. W, 
watts
*p0.05 intervention difference, **p0.01 intervention difference. 
#p0.05 significant correlation with CR or CC.  
 
In study II, the female athletes displayed significantly better CR than the males. Study III also 
contained both male and female subjects, and when combining CR results from these two 
studies divided by gender, there is still a significantly (p0.01) better CR between the female 
subjects (0.663  0.039 mlkg-0.75min-1) than the male subjects 
(0.724  0.057 mlkg-0.75min-1). The gender differences found in study II and III are in 
accordance with results from Helgerud (1994), who found that in performance matched male 
and female marathon runners, the women had better CR than the men. However, in the study 
by Helgerud (1994), the female runners had a higher weekly mileage than the male runners. 
This was not the case in study II or in study III. When results from study I, II and III are put 
together, there is no correlation between CR and LT expressed as %VO2max or LT velocity. As 
Franch et al (1998) relates improved CR to reduced ventilatory demand, and since paper III in 
this thesis demonstrates a significantly improved CR from pre to post intervention we 
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evaluated if VE in study III decreased according to the shown decrease in CR. There was a 
significant (R=0.74, p0.05) correlation between pre intervention VE expressed as Lkg-
0.67min-1 and CR, indicating a possible relationship between these variables, but there were no 
correlation between changes in VE and changes in CR. The correlation between CR and VE 
was supported in study IV (R=0.82, p0.01), as depicted in figure 4. 
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Figure 4  Linear regressions between VE and CR in study IV. 
CR, oxygen cost of running (mlkg-0.75m-1) measured at 15 kmh-1 on a level treadmill. VE, total pulmonary 
ventilation (Lkg-0.67min-1) measured at 15 kmh-1 on a level treadmill. p0.01, R=0.82. N=11. 
 
In study V, the cyclists showed a 7% improvement in brake power from pre to post 
intervention at the same relative intensity (70% VO2max). VE (Lkg-067w-1) stayed 
approximately the same from pre to post intervention when measured at both pre and post test 
brake power. This shows that the changes in VE are only apparent when measured at a set 
velocity or brake power, and must be taken into account when relating changes in VE to 
changes in economy. 
Maximal strength 
The long distance runners participating in study III had a considerably lower 1RM pre 
intervention in 90 half-squat (7321 kg) than soccer players (16125 kg) in Hoff and 
Helgerud (2003) and soccer players (13016 kg) in McMillan et al (2005). The runners 
managed in average to lift approximately 5 kg per kg body weight raised to the power 0.67 
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pre intervention, compared to the approximately 8 kg per kg body weight raised to the power 
0.67 among the soccer players. The finding in study III that pre intervention 1RM did not 
correlate with CR is interesting. Neither did improvements in 1RM correlate with 
improvements in CR. This indicates that not only improvement in muscle strength measured 
as 1RM, but also other factors affecting CR were improved by the MST.  
 
A possible way to improve CR might be to increase the amount of energy from the braking 
forces that can be stored in elastic elements in muscle-tendon units (elastic recoil). In this 
respect strength training has been reported to increase muscle – tendon stiffness (Kubo et al 
2001). Neither muscle–tendon stiffness nor elastic recoil was measured in any of the studies 
presented in the present thesis.  The improvements in CR after an MST intervention shown in 
study III may thus be due partly to an improvement in the ability to store energy from the 
braking forces in elastic elements in muscle-tendon units, but to investigate this, muscle–
tendon stiffness should have been measured pre- and post the MST intervention.  
Another way in which CR may be improved is by increasing muscular efficiency. The MST 
intervention for running (study III) may thus also have improved muscular efficiency. In 
study V the same improvements in economy as in study III were echoed, this time regarding 
cycling. Elastic storage of energy should logically not be as important in cycling as in 
running. Since the same improvements in economy as in running were found in cycling after 
the MST intervention, we suggest that muscular efficiency adaptations have exceeded 
adaptations regarding elastic recoil in the two studies.  Muscular efficiency covers a variety of 
factors (Alexander 1984, Tokui and Hirakoba 2007).We suggest that the main sources to the 
economy adaptations to MST found in study III and study V are neural adaptations, discussed 
more thoroughly in the next passage. Theoretically the MST could also have led to 
hypertrophic adaptations. But neither the runners in study III nor the cyclists in study V 
changed their body weight from pre- to post intervention, as shown previously by Hoff et al 
(2002), Hoff et al (2002), Helgerud et al (2003), Hoff et al (2005) and McMillan et al (2005).  
A possible hypertrophic response to MST among well trained athletes should be detected as 
an increase in body weight.  
 
Rate of force development 
In study III, a significant correlation between pre intervention RFD and CR was observed. The 
same finding was repeated in cycling (study V). RFD also improved significantly in the two 
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MST interventions (study III and V). In study V highly significant correlations between 
improvements in RFD and improvements in tMAP were found (p0.01, R=0.75). These 
results may indicate a relationship both between RFD in the muscles active in running and 
cycling and economy, as well as a relationship between improvements in RFD and time to 
exhaustion at a given intensity in cycling. RFD is logically related to contraction time in 
working muscles. A shorter contraction time will logically prolong transit time at a given 
cyclus frequency. An increase in RFD could also lead to a shorter CT in a running step. 
However, in study IV no correlation between CT and CR was found. The results from study 
IV are thus in line with Williams and Cavanagh (1987) and Kyrolainen et al (2001) who 
found no significant correlation between CT and CR. Even though no correlation was found 
between CT and CR in study IV, it does not necessarily mean that CT was not affected by the 
MST in study III, but CT was not measured in this study. The increase in RFD found in 
studies III and V may represent a more effective activation of motoneurons and muscle fibers 
as discussed in Hoff et al (2002). If less motor units need to be recruited at the same time at a 
given intensity, more unfatigued motor units will be available during prolonged exercise, and 
a longer time to exhaustion at a specific intensity might be expected. Better tMAS and tMAP 
was shown in studies III and V. The results from these studies thus support the hypothesis of a 
more optimal activation of motoneurons and muscle fibers.  
 
Running and cycling characteristics and force measures 
In study V, the cyclists always used a freely chosen cadence (RPM). In both the MST 
intervention group and in the control group, the mean cadence at 70% VO2max was on average 
95 RPM. There was no change in cadence after the MST intervention, although the 
intervention group improved their 1RM, RFD and CC significantly. This is in line with results 
on double poling frequency in cross-country skiing (Hoff et al 1999, Hoff et al 2002, Østerås 
et al 2002). The results from study V are however in contrast to previous studies that have 
shown gross efficiency among elite cyclists to be significantly higher at a lower cadence than 
their freely chosen cadence (Foss and Hallen 2004), and that better economy is related to 
lower cadence (Hansen et al 2007). The cyclists in study V might have shown an even better 
CC if the freely chosen cadence had been replaced by a set cadence. Theoretically, with an 
increased muscular strength, a cyclist can lower the cadence and still produce the same 
relative force in each pedal revolution at a given brake power. On the other hand, the cyclist 
may choose to maintain the cadence and then lower the relative force needed in each pedal 
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revolution at the same given brake power. The latter may be the most common pattern if 
freely chosen cadence is primarily a robust innate voluntary motor rhythm, as proposed by 
Hansen and Ohnstad (2008). If, as a result of MST, RFD increases, it would be an indication 
of a higher maximal muscle-shortening velocity. In study V the relationship between 
RFD/cadence and CC was found to be highly significant (p0.01, R=0.84) and the correlation 
was higher than that between RFD alone and CC (p0.01, R=0.76). This may indicate that the 
lower the relative muscle-shortening velocity needed for a given cadence, the better cycling 
economy.  
 
There is a difference between cadence in cycling and stride frequency in running. Within a 
small range of pedal arm lengths available, the cyclist has to choose one. Once the pedal arm 
length is chosen, it stays the same throughout training or the race. Runners can vary stride 
lengths within a much larger range compared to the range of different pedal arm lengths in 
cycling. Also, the runners may vary stride lengths during training or a race.  Previous studies 
on stride frequency in running have shown that the runners freely chosen stride frequencies 
correspond well with the optimal stride frequencies regarding CR. In a study by Hunter and 
Smith (2007), the self optimized stride frequency among 16 experienced runners, which was 
both the self-selected one and the one expressing the best CR, averaged 87 steps per minute. In 
study IV the mean stride frequency averaged 89 steps per minute and the result is thus in line 
with Hunter and Smith (2007). The stride frequency measured in study IV was also found to 
have a low variation between the subjects. Corrected for leg length, all runners chose 
approximately the same ratio between stride length and stride frequency. It seems thus logical 
that no correlation between stride frequency and CR was found in study IV. 
 
When maintaining a given running velocity on a treadmill, the sum of horizontal brake forces 
and the sum of horizontal propulsive forces in each step must be equal. The same applies for 
the vertical forces regarding the position of centre of gravity. In study IV we measured 
horizontal and vertical brake and propulsive forces. Average peak braking and propulsive 
forces, horizontal or vertical, need of course not be equal in each step, as it is possible to 
change position on the tread mill. However, the brake forces measured are approximately of 
the same size. In study IV none of the average peak force measures correlated significantly 
with CR. However, the sum of horizontal and vertical eccentric and concentric peak forces 
(APFtotal) showed a significant inverse correlation with CR (p0.05, R = 0.66). If the braking 
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forces are large, the runner will consequently need large propulsive forces to maintain the 
velocity (horizontal) or maintain position of the centre of gravity (vertical). Thus, if only 
braking forces are taken into account, only about half of the size of the peak forces actually 
produced is measured. This may reduce the differences between runners. Both vertical and 
horizontal forces are each previously found to influence CR. Farley and Mcmahon (1992) and 
Kram and Taylor (1990) have found CR to be inversely proportional to the weight supported, 
i.e. directly dependent on the vertical forces, whereas Chang and Kram (1999) have found 
horizontal forces to constitute more than 33% of the total metabolic cost of horizontal running 
on treadmill. And for running on track, Kyrolainen et al (2001) actually found that the 
average horizontal forces in the braking phase of the step could explain more than 80% of CR.  
 
Maximal oxygen uptake  
In studies I and IV, the subject groups are homogenous regarding VO2max. In studies II, III and 
V the groups of subjects are more heterogeneous regarding VO2max. Data from studies I, II 
and III (n=39) show a significant correlation between VO2max and LT velocity (R = 0.85, 
p0.01). This indicates that among these subjects VO2max explains 72% of the inter-individual 
difference in LT velocity. In cycling in study V (n=13), there is also a high, although 
somewhat lower correlation between VO2max and LT brake power (R= 0.75, p0.01), 
indicating that among these subjects VO2max explains 57% of the inter-individual difference in 
LT brake power. Time performance data were collected from the athletes at 5000m and 
3000m in studies III and IV respectively. Recalculating the 3000m times from study IV by 
using the equation by Riegel (1981): t2 = t1 * (d2 / d1)1.06 (equ. 4), 5000m performance times 
for all the athletes in study III and IV can be put together. The heterogeneity regarding VO2max 
then consequently increases, as the athletes in study III are well trained whereas the athletes in 
study IV are elite and have much higher VO2max values. A highly significant correlation (R= 
0.92, p0.01) then appears between competition time performance and VO2max, as depicted in 
figure 5. This points at a larger relative importance of VO2max in groups that are more 
heterogeneous regarding VO2max. 
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Figure 5     Linear regressions between VO2max and 5000m time performance in study III 
                    and V 
VO2max, maximal oxygen consumption (mlkg-0.75min-1). 5000m time, seasonal best time performance in 5000m 
competition (in seconds). p0.01, R=0.92. N=28. 
 
Lactate threshold 
In study I La-b was found to decrease 31.2% during the 5 minute run at LT velocity with a 
pre La-b of 5 mmolL-1, determining LT velocity from running velocity at 1.5 mmolL-1 
above post warm up values according to Helgerud (1994). This is a strong indication of an 
underestimation of LT velocity. Also during the running session at LT velocity with a pre 
La-b of 3 mmolL-1, La-b was found to decrease significantly by 21.8%.  
 
In studies I, II and III put together we found LT velocity to correlate highly with VO2max but 
not with CR alone. The high correlation between aerobic endurance performance and LT 
velocity is not surprising since the velocity then will depend on both VO2max and CR. Also in 
studies III and IV performance characteristics measured as time performance in 5000m and 
3000m running respectively were collected. The results from study III correlated highly with 
LT velocity among the subjects, whereas LT was not measured in study IV. But although LT 
velocity in intervention studies has been shown to change with the alteration of VO2max and- 
or C, in terms of the percentage of VO2max the adaptability has been found to be minor 
(Bangsbo 1994, Helgerud et al. 2001). The latter thus seem to be in accordance with the 
results from studies I, II and III that LT expressed as %VO2max does not correlate with either 
time performance in 5000m or 3000m running, or with MAS. In table 2, LT expressed as % 
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VO2max is very consistent between all three groups of athletes regarding running, with no 
significant difference of means. The variation between means in these three different studies 
is only 0.7%.  
Only study III contains data from VO2max, CR, LT and time performance (5000m). If a 
performance equation (VO2max / CR) is used in study III, the correlation between VO2max / CR 
and time performance in 5000m is high (R= 0.82, p0.01). If this performance equation is 
expanded, multiplying (VO2max / CR) with LT expressed as % VO2max, the correlation gets 
even higher (R=0.86, p0.01). This indicates that among these athletes, the relative 
importance of LT expressed as % VO2max is approximately 7% (figure 6). 
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Figure 6  Relationship between endurance performance equation including LT and 
5000m time performance in study III 
Endurance performance equation, (VO2max / CR)  LT expressed as % VO2max. VO2max, maximal oxygen 
consumption (mlkg-0.75min-1). CR, oxygen cost of running at 70% VO2max. LT, lactate threshold.  5000m time, 
seasonal best time performance in 5000m competition (in seconds). p0.01, R=0.86. N=15. 
 
The relative importance of cost of running on distance running 
performance 
When the seasonal best time performance data from the athletes in study III and IV are put 
together, there is significant correlation (R= 0.92, p0.01) between 5000m time performance 
and VO2max (figure 4). The heterogeneity regarding VO2max is consequently high (variation of 
17.4%), as the athletes in study III are well trained whereas the athletes in study IV are elite 
and have much higher VO2max values. The correlation between VO2max / CR and 5 km 
performance show an R = 0.94 (p0.01), indicating that CR should account for 4% of the 
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difference in 5 km performance between subjects. In study IV alone, with a more 
homogenous group regarding VO2max (variation of 7.0%), the combination of VO2max and CR 
correlated with time performance with an R = 0.93 (p0.01). The correlation between VO2max 
alone and time performance showed an R = 0.85 (p0.01). This indicates that CR accounts for 
13% of the difference in time performance between subjects in study IV, and that the relative 
importance of CR on distance running performance increases with increasing homogeneity 
regarding VO2max. This supports the finding by Conley and Krahenbuhl (1980) in highly 
trained and experienced runners with similar VO2max, where running economy accounted for 
65% of the variation observed in performance on a 10 km race. 
The relative importance of Cost of cycling on cycling performance 
In study V, competition time performance results were not collected from the cyclists as road 
racing results are not comparable. But a performance equation (VO2max / CC)  LT gives a 
good picture of physiological performance capacity. The performance equation thus shows a 
high correlation with VO2max (R = 0.77, p0.01) and a much better correlation with VO2max / 
CC (R = 0.94, p0.01), indicating a relative importance of CC of approximately 29% for 
physiological performance capacity in cycling among the cyclists in study V. This is higher 
than the relative importance of CR on running performance in studies III and IV. Of course the 
studies can not be uncritically compared as time performance results were not directly 
measured among the cyclists. 
Limitations of the studies in this thesis and future research 
The discussion of gender differences in CR in paper II would have benefited from a larger 
number of female athletes. Although the gender differences were large and highly significant, 
the statistical power would have increased with more than 6 female athletes. With 10 female 
athletes, given the same average gender differences in CR, the statistical power would increase 
by approximately 25% .To repeat this study design with more female runners would thus be 
of interest. The improvements in CR after an MST intervention shown in study III may be due 
partly to an improvement in the ability to store energy from the braking forces in elastic 
elements in muscle-tendon units. To confirm or disprove this hypothesis, muscle–tendon 
stiffness could have been measured pre- and post the MST intervention, but this was not done 
in study III. To repeat this study design with the addition of muscle–tendon stiffness 
measurements as well as measurements of contact time and time to peak force may increase 
the knowledge about the causes of CR adaptations to MST. 
 48
 Running performance data expressed as time results in long distance running were only 
collected in papers III and IV. Papers I and II would have benefited from such data to classify 
the athletes running ability. Also these data would have provided a more thorough discussion 
of the relative importance of CR on distance running performance in this thesis. The same 
applies for study V on cycling. An ergometer cycle time trial could have given directly 
measured time performance results. To repeat the study design of study V with the addition of 
ergometer cycle time trials could thus be valuable. In studies III and V, RFD pre intervention 
was found to negatively correlate with CR and CC, meaning that the subjects with the best 
RFD had the best work economy. Study IV would have profited on measurements of RFD in 
addition to maximal strength measurements. The study design of study IV should thus be 
repeated with additional measurements of RFD.   
 
Conclusions 
Running economy was found to correlate significantly inverse with the sum of average peak 
horizontal and vertical forces in each running step. Running economy was found to 
deteriorate with increased levels of lactate. Women were found to have better running 
economy than men. Both running and cycling economy was found to correlate significantly 
positive with rate of force development in half-squat. Body fat percentage and height were 
found to correlate moderately inverse with running economy. From the investigations 
presented in this thesis, the sum of average peak horizontal and vertical forces in each running 
step, blood lactate concentration, rate of force development, gender, body fat percentage and 
height were found to be determining factors for running economy, while rate of force 
development was found to be a determining factor for cycling economy. 
An incremental protocol for assessing running economy was found to reliably calculate 
running economy in a cross-over study. Running economy was found to be unaffected by 
running intensity in the area between 60% and 90% of maximal oxygen consumption. 
Both running and cycling economy was found to be improved significantly after eight weeks 
of maximal strength training in half-squats. These improvements led to improved time to 
exhaustion at maximal aerobic speed and time to exhaustion at maximal aerobic power. The 
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maximal strength training interventions did not alter body weight or maximal oxygen 
consumption. 
Practical applications 
Practical implications from the research presented in this thesis is first and foremost based on 
the finding that maximal strength training, with emphasis on maximal mobilization and thus 
neural adaptations, improves both running economy and cycling economy, as long as the 
maximal strength training is a supplement to the subjects regular endurance training. Maximal 
strength training can thus serve as a useful tool for enhancing endurance running and cycling 
performance.  
 
Evaluation of running economy in long distance runners can be based on testing at any 
running velocity representing intensity between 60 – 90% of maximal oxygen consumption. 
The finding that running economy is impaired with increasing blood lactate concentration, 
points to the importance of finding a suitable intensity, with as little accumulation of blood 
lactate as possible at the start of an endurance race. The sum of average peak horizontal and 
vertical forces in each running step is found to be negatively related to running economy. This 
indicates that a minimizing of the external vertical and horizontal forces during running may 
improve running economy. How to make such adaptations through training is however a 
complex task, but one logical approach may be to try to minimize the vertical movement of 
the centre of mass.  
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 ABSTRACT
Purpose: The present study investigated if there are differences in running economy at 
different velocities for well trained distance runners, and to what extent a commonly used 
incremental protocol for measuring oxygen uptake (VO2) at different velocities affects the 
reliability of these measurements.  
Methods: 15 well trained distance runners (9 male and 6 female) participated in this study. 
Gross oxygen cost of running (CR), heart rate (Hf) and La-b during 5 minute runs at 
velocities ranging from 8.0 to 17 kmh-1, representing intensities ranging from 60% to 90% of 
maximal oxygen consumption (VO2max) was measured on two different days in random order. 
The athletes were also tested for lactate threshold (LT), VO2max and time to exhaustion at 
MAS (tMAS).  
Results: No significant differences in CR between the different relative velocities or the 
different set velocities were found up to 90% of VO2max. The incremental protocol for 
measuring VO2 at different velocities was found not to affect the reliability of these 
measurements. All athletes reached their VO2max while running to exhaustion at MAS. The 
females showed significantly lower VO2max but significantly better CR than the males.  
Conclusion: At velocities representing intensities between 60% and 90% of VO2max, no 
differences in CR were found. The commonly used incremental protocol for measuring 
oxygen uptake (VO2) at different velocities was found not to affect the reliability of these 
measurements. This means that CR measured at sub maximal velocities are representative for 
CR at race velocity for distances above 10 000 metres for most runners. 
Keywords: Oxygen cost of running; running velocities; test protocol. 
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 INTRODUCTION
Endurance performance, as in long distance running, imposes great demands on both the 
cardiovascular system and the employed locomotor organs. A model described by Pate and 
Kriska (1984) incorporates three major factors accounting for interindividual variance in 
aerobic endurance performance, namely maximal oxygen consumption (VO2max), lactate 
threshold (LT) and work economy. This model is supported by numerous published studies 
(Pollock, 1977, Farell et al., 1979, Conley and Krahenbuhl, 1980, Di Prampero et al,. 1986, 
Bunc and Heller, 1989, Helgerud, 1994). Maximal aerobic speed (MAS), or the minimum 
speed needed to reach VO2max (vVO2max) has been explained by Morgan et al., (1989) as the 
VO2max divided by CR. Noakes et al., (1990) have shown that maximal speed reached during 
VO2max testing correlates better with performances for distances between 10 and 90 km than 
VO2max alone. In accordance with this, Lacour et al., (1990) found that CR or VO2max alone did 
not correlate with race velocity among well trained middle and long distance runners (800m-
5000m), whereas MAS correlated well with the race velocity for distances longer than 800m. 
The MAS has been found to represent 1500m - 3000m velocity in elite and sub-elite distance 
runners (Lacour et al., 1990, Billat & Koralsztein, 1996, Bassett et al., 2003). The time to 
exhaustion at MAS in these studies was approximately 3-9 minutes. 
CR is commonly defined as the steady rate VO2 in ml·kg-1·min-1 at a standard velocity (Costill 
et al., 1973, Conley and Krahenbuhl, 1980) or as energy cost of running per metre (mlkg-1m-
1) (Di Prampero et al., 1986, Helgerud, 1994, Helgerud et al., 2001). It is also expressed as 
mechanical efficiency, which is referred to as the ratio between work output and oxygen cost 
(Åstrand and Rodahl, 1986). 
Conley and Krahenbuhl (1980) and Helgerud (1994) have shown inter-individual variations in 
the oxygen cost of running (CR). The causes of this variability are not well understood, but it 
seems likely that anatomical trait, mechanical skill, neuromuscular skill and storage of elastic 
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 energy are important factors (Pate and Kriska, 1984). Interindividual variability in CR reflects 
the importance of this parameter for performance in long distance running. Interindividual 
variability in CR expressed as standard deviations (SD) is reported by Di Prampero et al. 
(1986) to be 8 %, if the CR is expressed per kg body mass. This is in line with results from 
Morgan et al. (1995) and Lacour et al. (1990). These results are also expressed per kg body 
mass. 
Energy cost for movement does not increase in the same rate as body mass (Bergh et al., 
1991, Eisenmann et al., 2001, Berg, 2003). According to Helgerud (1994), a lack of 
allometric scaling will underestimate VO2max and overestimate CR among the heavier runners. 
Consequently, part of the variation in CR in the experiments by Di Prampero et al. (1986), 
Morgan et al., (1995) and Lacour et al., (1990) are due to body mass differences. To use 
allometric scaling when expressing CR has seemed to reveal smaller differences. Helgerud 
(1994) has reported SD for CR of approximately 5% within intermediate national elite 
marathon runners when expressing CR per kg body weight raised to the power of 0.75 and 
metre. In accordance with this, Helgerud et al. (2001, 2003) have shown SD for CR to be 5% 
in junior soccer players and 3-4% in adult players including a group of players at European 
Champions League level. Hoff et al. (2005) report SD for CR to be less than 5% among 36 
professional soccer players.  
Helgerud (1994) has reported a lower CR at velocities equal to LT among female intermediate 
national elite marathon runners than in their performance-matched male counterparts when 
expressing CR per kg body weight raised to the power of 0.75 and metre. Daniels and Daniels 
(1992) and Bunc and Heller (1989) did not report gender differences in CR when the results 
are recalculated (body weight raised to the power of 0.75 and metre). 
If measurements of CR at a sub-maximal running velocity are to be used to evaluate race 
performance capacity among long distance runners, the measurements should be 
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 representative for the CR at racing velocity. Previous investigations have shown CR to be 
independent of running velocity up to intensities close to VO2max for long distance runners (Di 
prampero et al., 1986, Helgerud, 1994). However Daniels and Daniels (1992) report 
increasing CR at increasing relative running velocities. They also found elite middle distance 
runners to have better CR at velocities at or above marathon pace than elite long distance 
runners. The long distance runners had better CR at velocities below marathon pace than the 
middle distance runners.  
In most studies that have investigated CR at different velocities, an incremental protocol with 
different sub-maximal work periods over 3-10 minutes each, have been used (Di Prampero et 
al., 1986, Bunc and Heller, 1989, Lacour et al., 1990, Helgerud, 1994). A possible cause of 
error in these protocols is the incremental order in which the runs have been performed. In 
this context it should be of interest to assess to what extent VO2 at one velocity is affected by 
previously completed runs. 
The aim of the present study was to investigate if there are differences in running economy at 
different velocities for well trained distance runners, and to what extent a commonly used 
incremental protocol for measuring oxygen uptake (VO2) at different velocities affects the 
reliability of these measurements.  
 The hypothesis of the present study was; 
1. There are no differences in CR at different velocities in male and female distance 
runners between 75-90% VO2max. 
2. The commonly used incremental protocol for measuring VO2 at different intensity 
levels is reliable up to 90% VO2max. 
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 MATERIALS AND METHODS 
Subjects: 15 moderately to well trained runners, 9 males and 6 females, aged 29.3  7.0 years, 
with an average VO2max of 65.2  10.4 ml·kg-1·min-1 were included in the study, after giving 
their written consent to participate.  
Test procedures: The subjects were tested on two different days, with a minimum of one day 
and a maximum of seven days of rest or easy training in between. The first day consisted of 
measurements of heart rate (HR), blood lactate concentration ([La-]b) and oxygen 
consumption (VO2) during five minutes runs (1.5% inclination) at different velocities until 
exhaustion. The subjects started with a velocity assumed to be about 60% of their VO2max. 
This was either 8.0 or 9.5 km · hour-1.  After completing five minutes at this velocity, the 
speed was increased by 1.5 km · hour-1 to the next five minute work period. New steps were 
performed until the subject no longer could complete five minutes at the desired velocity. 
After 60 minutes of rest, a VO2max test was performed, using an incremental protocol at 5.2% 
inclination. The VO2max test terminated at voluntary fatigue by the subjects. HR ( 98 % 
predicted HRmax), R ( 1.05) and La-b ( 8.0 mmol · L-1) values, as well as a possible 
platouing of the VO2 curve, was used to evaluate if VO2max was obtained. LT and maximal 
aerobic speed (MAS) were calculated on the basis of these measurements. The second day of 
testing consisted of measurements of HR, [La-]b and VO2 at the same velocities as the first 
day, but performed in the opposite order (i.e. starting with the highest running velocity after a 
warm up). Following a 60 min rest, the subjects then performed a run to exhaustion at MAS. 
The protocol for one of the runners is presented in table 1. 
Protocol for one of the runners (table 1). 
The VO2 was measured using the metabolic test system, Sensor Medics Vmax Spectra 
(SensorMedics 229 California, USA). The lactate measurements were performed using an 
Arkray Lactate Pro LT-1710 analyser (whole blood) (Arkray Inc. Kyoto, Japan). The LT was 
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 defined as the warm up  [La-]b value (i.e. measured after the lowest velocity in day one) + 1.5 
mmol. This is in line with the protocol proposed by Helgerud et al. (1990),  consisting of 
several five minute steps, at 1.5% inclination, increasing the speed by 1.5 km · hour-1 after 
each step. The oxygen cost of running was measured at the same 5-minute steps at 1.5% 
inclination. These steps were performed until the subjects no longer managed to run for 5 min 
(exhaustion). In day two the same velocities were measured, but in the opposite order. CR was 
calculated as gross oxygen cost per kilo bodyweight raised to the power of 0.75, per meter of 
running for the set running velocities. For the relative intensities, for example 75% VO2max, 
running velocity was calculated in the same way as for maximal aerobic speed (figure 1). 
Assessment of maximal aerobic speed (figure 1). 
MAS was defined at the velocity at 1.5% inclination of the treadmill, where the horizontal 
line representing VO2max meets the extrapolated incremental line representing the sub 
maximal VO2 measured in the LT assessment. By plotting VO2 data against running velocity, 
individual regression equations for each subject could be obtained.  Based on the findings of 
Helgerud (1994), values in between 60-90% VO2max were used to calculate the incremental 
line. An example of the assessment of MAS is presented in figure 1. 
Alometric scaling has been reported to decrease the SDs in CR between subjects (Helgerud, 
1994, Helgerud et al., 2001, Hoff et al., 2005). VO2 values are thus mainly expressed in  
ml  kg-0.75 in the present study. 
Statistical analysis: Descriptive statistical analyses were made to display means, standard 
deviations, standard error and coefficient of variance. To assess whether or not the VO2 
values would be affected by the preceding step (i.e. the day to day measures described above), 
two way ANOVA-tests were used. Differences in CR at different velocities and possible 
gender differences in CR were also tested by using two-ways ANOVA-tests. Linear 
regressions were made to display the equations representing the linearity between running 
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 velocity and oxygen cost of running. Correlations were calculated by the Pearson correlation 
test.  
  
RESULTS
Physical characteristics of subjects (table 2) 
Physical characteristics of the subjects are presented in table 2. There was no significant 
gender differences in age, in LT velocity, in LT expressed as per cent of VO2max or in tMAS. 
The male subjects were taller, heavier and had a higher VO2max than the females.  
To compare physiological parameters at VO2max and at MAS, only the participants that 
completed more than five minutes at MAS were included, independent of gender. They would 
thus have at least spent the same time at this intensity as at the set submaximal intensities. 
Further, five minutes should allow a possible steady rate to occur. These runners clearly reach 
their VO2max at MAS (99.4% of VO2max). Neither the results regarding HR nor [La-]b peak were 
different being obtained at VO2max or at MAS. However, the subjects exhibited significantly 
lower R-values when running at MAS compared with the R-values achieved during the 
VO2max test. These results are presented in table 3. 
Physiological variables at VO2max and at MAS (table 3)
Table 4 shows the mean values in VO2 at each of the set intensities by the 10 subjects who 
completed at least 15.5 km · h-1, independent of gender. The results are divided into the two 
different test days. In day one the subjects ran at the lowest velocity first, increasing the speed 
for each separate run. In day two they started at the highest velocity, decreasing the speed for 
each separate run.  
Oxygen cost of running at different test days (table 4) 
There were no significant differences in oxygen costs of running (CR) expressed as  
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 VO2 mlkg-0.75min-1 between the two test days. The coefficient of variation  for the mean 
differences between day one and day two is 0.9%. Consequently, only results from test day 
one, apart from the MAS results (day two) are used in the following statistical analysis.  
 
The mean data for CR expressed as VO2 ml  kg-0.75  m-1 at those of the set velocities that were 
completed by all the fifteen subjects are shown in table 5. These results are divided by gender. 
Oxygen cost of running at set velocities (table 5) 
There were no significant differences in CR expressed as VO2 ml  kg-0.75  m-1 between the 
different set velocities. The females had significantly lower CR than the males at the set 
velocities. Mean interindividual variability expressed as standard deviations (SD) for the 
males was 7.1%. For the females, mean interindividual variability was 5.2%.   
By plotting VO2 data against running velocity as described in the protocol for assessing MAS, 
individual regression equations for each subject could be used to find the cost of running at 
the different relative velocities. By using running intensities representing 75-90% of VO2max, 
the data are within the area of velocity completed by all the subjects. Table 6 shows the mean 
data for the CR expressed as VO2 ml  kg-0.75  m-1 at these velocities relative to VO2max.  
Oxygen cost of running at relative intensities (table 6, figure 2) 
No significant differences in oxygen costs of running expressed as VO2 ml  kg-0.75  m-1 
between the different relative velocities was found for the male or for the female subjects. The 
females had significantly lower oxygen cost of running than the males at all the relative 
velocities.  
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 DISCUSSION 
The major findings in this study are that oxygen cost of running (CR) did not differ for 
velocities between 75% and 90% VO2max, and that the commonly used incremental protocol 
for measuring VO2 at different intensity levels is reliable up to 90% VO2max. 
 
Cost of running at different velocities and intensities 
The finding that CR did not differ at the different set velocities or relative intensities is in 
agreement with reports from di Prampero et al. (1986) and Helgerud (1994). These results are, 
however, not in agreement with the results from Daniels & Daniels (1992) who found 
increasing oxygen cost of running as relative running intensity increased in the area between 
70% and 100% VO2max. 
 
Reliability of the incremental protocol for assessing oxygen cost of running 
When comparing the CR from test-day one and test-day two, using the two different protocols 
(incremental order day one, descending order day two), no significant differences were found. 
The coefficient of variation for the mean differences between day one and day two is only 
0.9%. Thus it seems safe to assume that the commonly used incremental protocol for 
measuring VO2 at different intensity levels is reliable up to 90% VO2max.
Interindividual variability in oxygen cost of running 
Interindividual variability in oxygen cost of running expressed as mean standard deviations 
for the three velocities completed by all fifteen subjects (SD) is 7.1% for the males and 
5.2% for the females in the present study. The variability is lowest at the lowest velocity (9.5 
kmh-1), and highest at the highest velocity (12.5 kmh-1). Interindividual variability is 
reported by di Prampero et al. (1986) to be ±8%, if the oxygen cost of running is expressed 
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 per kg body mass. Morgan et al. (1995) and Lacour et al. (1990) have found within group 
variations of about 20%. These results are also expressed per kg body mass. As energy cost 
for movement does not increase in the same rate as body weight, it seems likely that part of 
the variation in the oxygen cost of running in the experiments by di Prampero et al. (1986), 
Morgan et al. (1995) and Lacour et al. (1990) is due to weight differences. If allometric 
scaling had been used, these results would assumingly be more in line with those reported in 
the present study, since the use of allometric scaling when expressing running economy has 
revealed smaller differences (approximaltely ±5%) in previous investigations (Helgerud, 
1994, Helgerud et al., 2001, Helgerud et al., 2003, Hoff and Helgerud, 2003, Hoff et al., 
2005). 
  
Gender differences 
Although possible gender differences was not one of the original aims of the present study, 
the results showed better CR among the females than among their male counterparts. The 
populations are however small (9 males and 6 females). These results are in agreement with 
results from Helgerud (1994), but seemingly in contrast to results from Daniels and Daniels 
(1992) and Bunc and Heller (1989). If we recalculate the oxygen cost in the two studies by 
Daniels and Daniels, (1992) and Bunc and Heller (1989) by raising the body mass to the 
power of 0.75 and metre, the results tend to be more in agreement with the results in the 
present study and in Helgerud (1994). This phenomenon has not been explained in previous 
literature, assumingly because it has been concealed, as the results have not been scaled by 
raising body weight to the power of 0.75 and metre. Since the female subjects in the present 
study had considerable lower VO2max than the males, the gender differences in CR could be 
related to differences in VO2max. This would be in line with the suggestion by Woodruff et al. 
(2005) that runners with the highest VO2max tended to be less economical with respect to the 
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 change in VO2 from one velocity to the next. However, in our study no correlation was found 
between VO2max and CR when the subjects were divided by gender. We have thus no 
explanations to why women should have lower CR than men. Further investigations’ 
regarding this phenomenon is thus needed.  
 
Maximal aerobic speed 
Eight of the fifteen subjects in our study completed more than five minutes at MAS, 
independent of gender. This group clearly reaches their VO2max at MAS (99.4% of VO2max at 
MAS). The results regarding heart rate and lactate confirm this. However, the subjects had 
significantly lower R-values when running at MAS compared with the R-values achieved 
during the VO2max test. A possible explanation for this is the lower intensity at MAS than at 
the end of the VO2max test.  
We found a significant correlation between time at MAS and LT as per cent of VO2max for the 
male subjects, but not for the females. With LT representing a higher percentage of VO2max, 
the anaerobic contribution to the work done per metre at MAS should logically be smaller.  
 
Participating subjects 
The participating subjects in the present study are characterised as a heterogenous group with 
regards to running performance, VO2max and CR. However, they are all well trained runners. 
Thus it seems natural that the CR by the group as a whole is higher than reported for elite 
runners (Daniels & Daniels, 1992), intermediate national standard marathon runners 
(Helgerud, 1994) and recreational marathon runners (Helgerud et al., 1990). The mean CR 
among the males (0.755 ml  kg-0.75  m-1) correspond to a CR of 0.246 ml  kg-1  m-1, whereas 
the mean CR among the females (0.680 ml  kg-0.75  m-1) correspond to a CR of 0.243 ml  kg-1 
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  m-1. The present results are more in agreement with results from soccer players as reported 
by Helgerud et al. (2001) and by Hoff and Helgerud (2003).   
Conclusion
At velocities representing intensities between 60% and 90% of VO2max, no differences in CR 
were found. This means that CR measured at sub maximal velocities are representative for CR 
at race velocity for distances above 10 000 metres for most runners. The commonly used 
incremental protocol for measuring oxygen uptake (VO2) at different velocities was found not 
to affect the reliability of these measurements. 
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Table 2. Physical characteristics of the subjects
 males (n = 9) females (n = 6) 
Age (yr) 30.0  9.2 27.8  6.1 
Height (m) 1.80  0.06  1.68  0.12*  
Mass (kg) 76.9  5.0  62.0  11.2*  
HRmax (beats min-1) 187  8 190  9 
VO2max (mlkg-1min-1) 71.4  6.3  56.2  9.2*  
VO2max (mlkg-0.75min-1) 211.3  17.8 157.8  17.8*  
Rpeak 1.09  0.03 1.08  0.04 
[La-]b peak (mmoll-1) 10.7  1.8 9.8  1.7 
LT (kmh-1) 13. 7  1.0 11.5  1.6  
LT (% Vo2max) 82.6  6.35  82.2  2.4  
MAS (kmh-1) 16.5  1.6 14.0  1.9 
TimeMAS (s) 432.5  170.7 242.8  92.0 
Values are means  SD., HRmax, maximal heart rate. VO2max, maximal oxygen uptake. LT, lactate threshold. 
Rpeak,gas exchange ratio at Vo2max. [La-]b peak, highest blood lactate concentration reached during the VO2maxtest. 
MAS, maximal aerobic speed. TimeMAS, time until exhaustion at MAS 
* p  0.05 Significant different from male values. 
 
 
Table 3. Physiological variables at VO2max and at maximal aerobic speed (MAS)
 VO2max (n = 8) 5.2% incl. MAS (n = 8) 1.5% incl. 
Vo2max 66.4  8.8  66.0  8.7  
HR (beats min-1) 186  7 185  5 
R 1.08  0.04 1.02  0.04* 
[La-]b peak (mmoll-1) 10.5  1.8 10.5  2.4 
Values are means  SD. VO2, O2 uptake. HR, heart rate. [La-]b peak , blood lactate concentration.  
* p  0.01 Significantly different from Vo2max values.  
 
 
Table 4. Oxygen costs of running at different test-days
 VO2 mlkg-0.75min-1 (n = 10)  
Velocity  
(km·h-1) 
Day 1  
(incremental)
Day 2  
(descending)
 day two  
– day one 
9.5 117.6  8.2  114.8  7.7 -2.8  6.5  
11 135.8  11.3 130.9  12.1 -4.9  5.7  
12.5 153.4  14.3 154.0  14.7 0.6  6.9  
14 171.9  14.8 176.4  16.0 4.5  8.6  
15.5 187.2  14.4 193.4  14.5 6.2  10.8  
Values are means  SD. 
Incremental, velocities run in an incremental order. Descending, velocities run in a descending order. 
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Table 5. Oxygen costs of running at set velocities
Velocity  
(km · h-1)
VO2 mlkg-0.75m-1
Males (n = 9) 
VO2 mlkg-0.75m-1
Females (n = 6)
9.5 0.753  0.04  0.689  0.027* 
11 0.752  0.053  0.686  0.038* 
12.5 0.749  0.061  0.6757  0.049*  
Values are means  SD. 
*p0.01 Significantly different from males. 
 
Table 6. Oxygen costs of running at relative intensities
Intensity in 
% VO2max
VO2 mlkg-0.75m-1
Males (n = 9) 
VO2 mlkg-0.75m-1
Females (n = 6)
75% 0.753  0.049 0.684  0.037* 
80% 0.755  0.051 0.681  0.038* 
LT  0.755  0.055 0.672  0.043* 
85% 0.756  0.054 0.677  0.040* 
90% 0.757  0.056 0.675  0.042* 
Values are means  SD. 
*p0.01 Significantly different from males. 
 
 
LEGEND TABLE 1 
The table shows the protocol for one of the runners. The number of 5 minutes steps is individual, 
as well as the running velocities. Otherwise the protocol is the same for all runners. VO2max, 
maximal oxygen uptake. MAS, maximal aerobic speed. 
 
 
LEGEND TABLE 2 
Values are means  SD., HRmax, maximal heart rate. VO2max, maximal oxygen uptake. LT, lactate 
threshold. Rpeak, gas exchange ratio at Vo2max. [La-]b peak, highest blood lactate concentration 
reached during the VO2maxtest. MAS, maximal aerobic speed. TimeMAS, time until exhaustion at 
MAS 
* p 0.05 Significant different from male values. 
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LEGEND TABLE 3 
Values are means  SD. VO2, O2 uptake. HR, heart rate. [La-]bpeak, blood lactate concentration.  
* p 0.01 Significantly different from Vo2max values.  
LEGEND TABLE 4 
Values are means  SD. 
Incremental, velocities run in an incremental order. Descending, velocities run in a descending 
order.
LEGEND TABLE 5 
Values are means  SD. 
*p0.01 Significantly different from males.
LEGEND TABLE 6 
Values are means  SD. 
*p0.01 Significantly different from males. 
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LEGEND FIGURE 1 
Figure 1.  Assessment of maximal aerobic speed. 
The linear regression equation in figure 1 is: y = 3.9393x + 2.7963.  R = 0.9997. VO2max for this 
runner is 69.2 mlkg-1min-1. 70 % VO2max for this runner is 48.4 mlkg-1min-1. From the equation, 
the corresponding velocity is 11.7 km·h-1, which equals 195 m·min-1. CR expressed as mlkg-1m-1 
is thus 0.284 mlkg-1m-1. MAS is the velocity point where the horizontal line representing VO2max 
meets the extrapolated linear regression representing the sub maximal VO2 measurements. Here 
represented by a velocity of 16.9 km·h-1. 
LEGEND FIGURE 2 
Figure 2.  Oxygen cost of running at relative intensities. 
Values are means  SD.  
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